Spring 2020 Capsule

Capsule

Spring 2020

University of Maryland School of Pharmacy Magazine for Alumni and Friends

UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY TAKES LEAD IN EDUCATION, RESEARCH, PRACTICE, AND OUTREACH

IN THIS ISSUE:

FY ’18 Annual Report

DEAN’S MESSAGE

We all know someone. With an estimated 46.6 million Americans suffering from a mental illness, we all know someone. That someone might be a family member or a friend. It might be a co-worker. It could be the cashier at the grocery store we see each week. Or it could be ourselves.

Whatever your relationship to mental illness, you surely know its impact. And the complex nature of the wide array of disorders classified as mental illness.

During the last several decades, these disorders have moved out of the shadows, recognized as legitimate and complex medical conditions.

The University of Maryland School of Pharmacy has long been supporting patients who suffer from mental health disorders. Some of our earliest work in this area began in the 1980s when the School received its first contract from the state of Maryland to administer the pharmacy program in the state’s mental health facilities. That program has expanded to include the School’s oldest pharmacy residency program and clinical sites for our faculty.

The School also works with patients affected by substance abuse disorders, examines state and federal policies related to the prescribing of antipsychotic medications, and seeks to create new and improved treatment options for illnesses such as depression. And as an institution of higher learning, we educate our students — future health care professionals — on mental health disorders and the myriad treatment options that are available.

We are now also paying closer attention to the mental health needs of our community — our faculty, staff, and students — encouraging them to speak up when they need help and continuing to connect them with assistance resources.

This issue of Capsule details our work in this important area. It’s sobering to see it cataloged together in these pages. But it’s also inspiring to see all that we are doing to assist those who suffer and to reduce further suffering.

In the spirit of expertise, influence, and impact,

Natalie D. Eddington, PhD ’89, FAAPS, FCP Dean and Professor Executive Director, University Regional Partnerships

MISSION The University of Maryland School of Pharmacy leads pharmacy education, scientific discovery, patient care, and community engagement in the state of Maryland and beyond.

VISION We will achieve our mission by: • inspiring excellence in our students through a contemporary curriculum, innovative educational experiences, and strategic professional relationships.

• advancing scientific knowledge across the spectrum of drug discovery, health services, and practice based and translational research with significant focus on collaborative partnerships.

• expanding the impact of the pharmacist’s role on direct patient care and health outcomes.

• building and nurturing relationships with all members of our community.

• capitalizing on our entrepreneurial spirit to improve pharmaceutical research, practice, and education in Maryland and throughout the world.

PLEDGE We are proud to be critical thinkers, lifelong learners, and leaders who are sought for our expertise. We earn our reputation with the highest standards of personal ethics and professional conduct.

Students and education are central to everything we do.

We engage the community; together, we contribute to the improved health of society.

We celebrate the distinctive talents of our faculty, staff, and students. We honor our traditions and advocate for dynamic changes in pharmacy practice, education, and research. We create the future of pharmacy.

Capsule Contents University of Maryland School of Pharmacy Alumni Magazine

Spring 2020 Becky Ceraul, Capsule Editor Assistant Dean, Communications and Marketing School of Pharmacy Chris Zang, Director, Editorial Services Julie Bower, Assistant Director, Design Services University of Maryland, Baltimore Office of Communications and Public Affairs Special thanks to the following contributors: Ken Boyden, JD, EdD Associate Dean Development and Alumni Affairs Malissa Carroll Web Content Specialist Greer Griffith Director Annual Giving and Alumni Affairs Erin Merino Senior Marketing Specialist Amanda Wolfe Digital Media Specialist School of Pharmacy Student Government Association

We welcome your comments, news, and suggestions for articles. Send your ideas to Becky Ceraul at the University of Maryland School of Pharmacy, 20 N. Pine St., Room N302, Baltimore, MD 21201. Email: rceraul@rx.umaryland.edu; Telephone: 410-706-1690; Fax: 410-706-4012.

Copyright © 2020 University of Maryland School of Pharmacy

www.pharmacy.umaryland.edu

2

SCHOOL NEWS

8

COMMITTED TO WELL-BEING

15

FACULTY PROFILE

16

STAFF PROFILE

17 STUDENT NEWS 22 PRECEPTOR PROFILE 23 ALUMNI NEWS 27 ALUMNI PROFILE 29

DONOR PROFILE

30 RESIDENT PROFILE 31 ANNUAL REPORT Read More, See More, Share More!

Read in-depth biographies of faculty, see additional pictures of School events, and share School news with your friends on social media. More details on the articles covered in this issue of Capsule are available in an electronic version — online. You can view Capsule from any mobile device. Visit www.pharmacy.umaryland. edu/capsule and start learning more about the University of Maryland School of Pharmacy.

SCHOOL NEWS

$2 Million Grant Investigates Diversity, Recruitment, and Retention in Aging Research

Daniel Mullins

Jay Magaziner

Daniel Mullins, PhD, professor and chair of the Department of Pharmaceutical Health Services Research (PHSR) at the School of Pharmacy, and Jay Magaziner, PhD, MSHyg, professor and chair of the Department of Epidemiology and Public Health at the University of Maryland School of Medicine, have been awarded a three-year, $2 million grant from the National Institute on Aging (NIA) to examine diversity, recruitment, and retention in aging research. They will lead a collaborative team that includes researchers, community members, and other stakeholders to develop evidence-based strategies that investigators can use to help recruit and retain older adults and diverse populations in research, and establish a registry of West Baltimore community members who are willing to participate in NIAfunded clinical research studies.

“As co-principal investigators, Dr. Magaziner and I are excited to lead this stellar A-team collaboration that will help us determine the best strategies and methods for enhancing diversity in aging research,” says Mullins, who also serves as executive director of the Patient-Centered Involvement in Evaluating the Effectiveness of Treatments (PATIENTS) Program at the School of Pharmacy. “We want to facilitate effective bi-directional learning throughout this study, and learn from our community members what approaches they believe will work best in their communities, as well as have them learn from us about the importance of research and how participation can help them, their families, and their communities.”

Research has demonstrated that medications, medical devices, and behavioral interventions can be made safer and

2

c a psu l e

www.pharmacy.umaryland.edu

more effective for all people when clinical studies include diverse populations. However, addressing the wide range of physical, socioeconomic, and other barriers that prevent individuals from aging populations, as well as underserved populations, from participating in these studies remains a challenge for many researchers. Building on the pioneering patient engagement efforts led by the PATIENTS Program and cutting-edge research conducted by faculty in the Center for Research on Aging at the School of Medicine, this project uses a collaborative team-based approach to address existing knowledge gaps and assess the effectiveness of strategies designed to increase diversity among older adult participants in clinical research studies.

“Most medications and therapies are tested and brought to market based on studies conducted not only in younger people, but in a relatively homogeneous group of volunteers,” says Magaziner, who also serves as director of the Center for Research on Aging. “These are typically individuals who have never been diagnosed with a chronic illness and who are able to easily travel to and from the location where the study is being conducted, which is often not an accurate representation of the majority of people who will use these drugs in the real world.”

He adds, “Fortunately, times are changing. There is now a big push to include not only older adults in research, but also individuals from more diverse populations. Thanks to the expertise of the PATIENTS Program and the Center for Research on Aging, we will be able to have an impact in this important area.”

The study will use a mixed-methods approach that leverages both qualitative and quantitative methodologies to test and compare recruitment and retention strategies. It will primarily focus on three populations that are not often engaged in clinical research studies: older African-Americans, older adults with disabilities, and older adults who cannot leave their homes.

The research team will be divided into three cores (Executive, Community and Collaboration, and Aging Research and Bioethics), as well as an External Advisory Board that will provide guidance and advice on the study.

Researchers also will employ a process known as collaborative evaluation, which will engage community members and other stakeholders throughout the evaluation process.

At the conclusion of the study, Mullins and Magaziner estimate that approximately 3,000 West Baltimore community members will have been recruited into the registry, giving their consent to be contacted to participate in future NIA-funded clinical research studies. b

School Mourns Passing of Two Retired Faculty Members The School of Pharmacy lost two dear former faculty members recently with the passing of Robert Michocki, PharmD ’75, BCPS, and Ralph Blomster, PhD. Michocki, alumnus and professor emeritus in the Department of Pharmacy Practice and Science (PPS), passed away on Oct. 15.

“During his career at the School, Dr. Michocki impacted the lives of thousands of faculty, staff, and students,” says Natalie D. Eddington, PhD ’89, FAAPS, FCP, dean and professor of the School of Pharmacy. “His contributions to the School and the pharmacy Robert Michocki profession live on in the actions of our alumni, who so ably care for their patients, and in those faculty members who were fortunate to call him a colleague and who looked to him for mentorship and guidance.”

Michocki first graduated from the School in 1971, and immediately joined the faculty. While on faculty, he once again became a student, pursuing his Doctor of Pharmacy (PharmD) in the School’s post-baccalaureate PharmD program — a program he helped launch. Michocki served the School as chair of PPS from April 2003 to August 2006, as well as interim chair from July 1991 to September 1992, and January 1996 to July 1997. He maintained practice sites in internal medicine, geriatrics, and emergency medicine, as well as a long-running family medicine practice site at the University of Maryland Medical Center. He also had a 35-year career as a consultant at the Baltimore Veterans Affairs Medical Center.

Throughout his career, Michocki gave numerous presentations at professional conferences, published in peerreviewed journals, authored book chapters, and co-authored a book on drug use patterns. He retired from the School of Pharmacy in 2014, after 43 years of service.

“Dr. Michocki relished the time he spent with students, learning just as much from them as they learned from him,” says Eddington. “So strong was his connection to our pharmacy students that he was the School’s Teacher of the Year a recordbreaking 10 times.”

Michocki’s impact as an educator was not only felt at the School of Pharmacy, but across the University of Maryland, Baltimore campus. In 2011, the Department of Family and Community Medicine at the University of Maryland School of Medicine honored him with its Excellence in Teaching Award.

He also was named the School of Pharmacy’s Evander Frank Kelly Honored Alumnus in 2003. b

Blomster, professor emeritus in the Department of Pharmaceutical Sciences, passed away on Jan. 27.

“Dr. Blomster’s presence had an indelible impact on all of us at the School of Pharmacy,” says Natalie D. Eddington, PhD ’89, FAAPS, FCP, dean and professor of the School. “He championed the cutting-edge research conducted by our faculty and was committed to ensuring a superior Ralph Blomster education for all of our students, always welcoming an opportunity to share his knowledge and expertise with them. With his recent passing, we have lost not only a caring colleague and great scientific mind, but also a beloved friend. Our thoughts are with his family during this difficult time.”

After receiving his doctorate in pharmacognosy — the study of plants and other natural resources as a potential source for medicinal drugs — Blomster joined the faculty of the School’s former Department of Pharmacognosy, serving as professor and chair of the department from 1968 to 1979.

During that time, he journeyed to numerous South American countries, including Peru, Bolivia, and Brazil, where he spoke with traditional healers and collected samples of the plants they used to treat various illnesses. At the School, Blomster and his graduate students worked to isolate the active compounds in those plants, developing an anti-inflammatory compound and a wound-healing agent that were sold in Europe.

Blomster continued to serve as chair of the renamed Department of Medicinal Chemistry/Pharmacognosy until 1989.

During his tenure, Blomster diligently worked to increase the number of faculty members in the department, which grew from 15 in 1968 to 50 in 1996, as well as enhance research, graduate education, and funding within the department.

But it was in his teaching and mentoring that Blomster truly shined. A passionate educator, Blomster delivered enthusiastic lectures sprinkled with humorous anecdotes to keep his students engaged. He also took time to mentor junior faculty members. “He gave us advice, showed us the ropes, and helped us succeed,” says Alexander MacKerell Jr., PhD, the GrollmanGlick Professor of Pharmaceutical Sciences and director of the School’s Computer-Aided Drug Design Center.

Blomster retired from the School in 1996. b sp r i ng 2 0 2 0

3

SCHOOL NEWS

SOP Collaborates with emocha to Offer Comprehensive Clinical Adherence Solution The Center for Innovative Pharmacy Solutions (CIPS) at the School of Pharmacy is collaborating with emocha Mobile Health to expand the company’s clinician-led adherence solution offering. Through this collaboration, pharmacists in the School’s e-Health Center will provide patients with comprehensive medication review and reconciliation services through a mobile application that protects their privacy. emocha will offer this service to hospitals, health systems, and health insurers, with the goal to increase medication adherence, address medication-related problems, and manage the rising cost of care and readmission rates.

“We are excited to collaborate with this outstanding institution that has a strong track record of developing technology-enabled services to maximize patient engagement and improve adherence,” says Sebastian Seiguer, JD, MBA, who is CEO at emocha. “By leveraging the University of Maryland School of Pharmacy’s e-Health Center and expertise, we are able to provide the highest quality medication review to patients and have expanded our ability to rapidly address medication-related problems.”

It has been estimated that medication nonadherence costs U.S. health systems and payers between $100 billion and $289 billion annually in preventable hospitalizations, while resulting in poor health outcomes. Adverse drug events in the U.S. cause more than 1 million visits to emergency departments and approximately 350,000 hospitalizations annually. Through emocha, patients improve medication adherence with video Directly Observed Therapy (DOT) and a clinician-led support team. DOT is the gold standard for medication adherence, and emocha is the market leader in video DOT, with more than 70 customers and multiple independent studies validating greater than 90 percent adherence rates.

Patients enrolled in emocha’s video DOT programs use a Health Insurance Portability and Accountability Act (HIPAA) compliant mobile app to video-record themselves taking their medications while working with emocha nurses and health care workers. Patients can report side effects, access local resources, receive medication reminders, and track their

4

c a psu l e

www.pharmacy.umaryland.edu

treatment progress. This collaboration with the School of Pharmacy expands emocha’s solution to add optimization of medication regimens offered by the medication experts — pharmacists in the School’s e-Health Center.

In addition to behavioral factors, a significant barrier to adherence includes medication problems ranging from improper drug administration to incorrect dosage. The collaboration between emocha and the School of Pharmacy’s CIPS will facilitate the management of medication-related problems that impact adherence. “Incorporating pharmacists who work in the School’s e-Health Center into the emocha program to confirm that patients follow correct technique, and to provide timely interventions to solve drug-related problems such as side effects and maximize therapeutic outcome, makes emocha the most comprehensive solution to medication nonadherence in the world,” Seiguer says.

“At the University of Maryland School of Pharmacy, we focus on providing highly supportive services to patients through comprehensive medication review and reconciliation to prevent and reduce drug-related problems,” says Magaly Rodriguez de Bittner, PharmD ’83, BCPS, CDE, FAPhA, director of CIPS and associate dean for clinical services and practice transformation at the School. “emocha is leading the way on the development of health-related technologies, and we are pleased to collaborate with them to provide medication therapy management services to a wide array of patients using this technology.”

“The Center for Innovative Pharmacy Solutions’ collaboration with emocha truly demonstrates the School’s Pharmapreneurship™ initiative in action and is characterized by leadership, expertise, and new venture design,” says Natalie D. Eddington, PhD ’89, FAAPS, FCP, dean and professor of the School. “By collaborating with a technology startup company in Baltimore City to deliver medication therapy management services to patients, CIPS is meeting a market need, with the ultimate goal of improving patient outcomes, reducing health care costs, and reducing hospital readmission rates.” b

$1.6 Million Grant Examines Impact of Antipsychotic Drug Reductions in Long-Term Care Facilities Linda Wastila, PhD, BSPharm, MSPH, the Parke-Davis Chair of Geriatric Pharmacotherapy in the Department of Pharmaceutical Health Services Research, has received a three-year, $1.6 million grant from the National Institutes of Health to investigate how a recent nationwide initiative to reduce the use of antipsychotic medications among older Linda Wastila adults in long-term care facilities has impacted the use of other medications at those facilities, as well as patient health outcomes.

“The organizations involved in this initiative have done an excellent job reporting the reductions in the use of antipsychotics, but our team will be the first to examine how efforts to reduce the use of this class of medications impacts the use of other medications and health outcomes for older adults in long-term care facilities,” says Wastila, who also serves as the director of research for the Peter Lamy Center on Drug Therapy and Aging at the School.

Antipsychotics are a class of medications primarily used to manage symptoms associated with psychosis, including delusions, hallucinations, and paranoia. While these medications are typically used to treat patients diagnosed with conditions such as schizophrenia and bipolar disorder, some health care professionals also prescribe them to patients diagnosed with Alzheimer’s disease and other related dementias. Prolonged use of these medications is associated with a number of adverse effects, which can be particularly detrimental for older adults.

The national initiative leading the effort to reduce the use of antipsychotic medications among older adults in long-term care facilities is known as the National Partnership to Improve Dementia Care. It is a private-public coalition established in 2012 that includes the Centers for Medicare and Medicaid Services (CMS), consumers, advocacy organizations, health care providers, and professional associations. Within five years of its launch, the initiative saw a 34.1 percent reduction in the use of antipsychotics across all long-term care facility residents, to a national annual prevalence of 15.7 percent – a number that continues to decrease each year.

“We absolutely believe that antipsychotics have been overused in the general population, as well as in long-term care facilities,” confirms Wastila. “But we are also concerned about the inadvertent, but very real, impact that a policy such as this might have when the only goal is to reduce the use of these medications by a certain percentage. Were these patients switched to other medications? What impact might those medication changes have had on patients?”

For Wastila, this study represents a continuation of her well-recognized work examining drug use among older adults. She and her team will use advanced methodological approaches and comprehensive national data — including a nationally representative, 100 percent sample of Medicare beneficiaries who resided in long-term care facilities from 2010 to 2016 — to assess state-, facility-, and individual-level characteristics that might have mediated the impacts of the nationwide initiative that affected more than 1.4 million longterm care facility residents. The team will focus on residents with Alzheimer’s disease and related dementias to assess the initiative’s impact on changes in the use of antipsychotics; potentially harmful use of other psychopharmacological medications, such as opioids, antidepressants, and anticonvulsants; and selected public health and individual patient health outcomes.

“One element of this study that really excites our team is that we have the opportunity to build a close-to-100 percent sample of all Medicare beneficiaries who resided in long-term care facilities for an extended period of time,” says Wastila.

“Oftentimes, the sample sizes used in studies such as this one are too small to allow us to see what is going on at the facility level. For this study, we can look at all of the patients in all of the facilities that receive funding from Medicare – that is approximately 90 to 95 percent of all long-term care facilities in the nation.”

She adds, “It also allows us to look at how facility characteristics — such as size, profit status, and staffing patterns — influence antipsychotic and other medication use and outcomes.”

The ultimate goal of the research is to provide guidance to health care providers and policymakers on how to optimize prescribing decisions for older patients in long-term care facilities. b

sp r i ng 2 0 2 0

5

SCHOOL NEWS

Palliative Care Program Celebrates First Convocation Faculty and staff from the School of Pharmacy joined family and friends on Aug. 16 to celebrate the first graduating class of the online Master of Science (MS) and Graduate Certificates in Palliative Care program. “I am incredibly proud and excited to host the first graduation celebration for our online MS and Graduate Certificates in Palliative Care program,” said Mary Lynn McPherson, PharmD ’86, MA, MDE, BCPS, CPE, professor and executive director for advanced postgraduate education in palliative care in the Department of Pharmacy Practice and Science (PPS) at the School of Pharmacy. “While all of the students in our program are amazing, this first cohort holds a special place in my heart.”

The ceremony began with remarks from Jill A. Morgan, PharmD, BCPS, BCPPS, professor and chair of PPS at the School of Pharmacy, and Mary Jo Bondy, DHEd, MSH, PA-C, assistant dean of graduate academic programs at the University of Maryland, Baltimore (UMB) Graduate School, who assured graduates that they have been provided with the knowledge and skills necessary to lead the development of palliative care and hospice services at their workplaces and encouraged them to take the next step in advancing their careers.

“Earning your master’s degree or graduate certificate in palliative care now positions you to make an incredible impact in your field,” Morgan said. “You have been well-prepared to engage more deeply and fully in your careers — caring for your patients, developing hospice or palliative care programs, earning promotions, or specializing in a specific area within palliative care. I encourage you all to go out and take great care of your patients and the profession. Truly, there is no limit to what you can achieve.”

“UMB is on a mission to solve real-world problems,” added Bondy. “Through your education and training, you are now uniquely prepared to help us fulfill this mission. With your expert understanding of the social, spiritual, and health care needs of patients dealing with chronic and end-of-life illness, you are well-equipped to guide and lead the delivery of care for this vulnerable population.”

Martha Martin, MD, MS ’19, consulting psychiatrist at

Millie Whyte, MS ’19, is hooded by Jill Morgan, professor and chair of the Department of Pharmacy Practice and Science (PPS), and Cherokee Layson-Wolf, associate dean for student affairs and associate professor.

Montgomery Hospice, delivered the message from the class.

She emphasized how the numerous unique features of the two-year program, including its flexible format, interdisciplinary coursework, and emphasis on student creativity, came together to foster an experience for students that not only facilitated professional learning, but also personal growth.

“We have been challenged, but it has been the best kind of challenge,” Martin said. “We had the extraordinary privilege of being taught by all of the pioneers in this developing field — luminaries lighting the path for us as we join the ranks of professionals dedicating our lives to this burgeoning field. We are now all a part of something far greater than ourselves, and we too are contributing to the richness of the future.”

Established in 2017, the online MS and Graduate Certificates in Palliative Care program addresses the growing need for interprofessional education across the fields of hospice and palliative care. The program is well-suited for a wide range of professionals, including physicians, pharmacists, thanatologists, nurses, advanced practice nurses, physician assistants, psychologists, social workers, chaplains, and administrators. It is designed for any professional who currently works or wishes to work in hospice and palliative care, and who wants to gain a deeper understanding of the field. b

The MS and Graduate Certificates in Palliative Care Class of 2019 with Mary Lynn McPherson (right), professor of pharmacy practice and science and executive director for advanced postgraduate education in palliative care.

6

p su l e c a psu

www.pharmacy.umaryland.edu www.pharmacy.umaryland.edu

Laurels The following School of Pharmacy staff members have been accepted into the University of Maryland, Baltimore’s (UMB) Emerging Leaders Program for the 2019-2020 academic year: • Malissa Carroll – Office of Communications and Marketing • Nicole Derr – Dean’s Office • Shardai Jones – Department of Pharmaceutical Health Services Research • Erin Merino – Office of Communications and Marketing • Kristina San Juan – Department of Pharmaceutical Sciences Nicole Brandt, PharmD ’97, MBA, BCPP, CGP, FASCP; Joshua Chou, PharmD ’17; and Barbara Zarowitz, PharmD, received the Top Poster Award at the 2019 Annual Meeting of the American Society of Consultant Pharmacists in Texas in November.

Kimberly Claeys, PharmD, has been named a 2019 Outstanding Reviewer by the journal Pharmacotherapy.

Andrew Coop, PhD, has been named the 2019 Maryland Chemist of the Year by the Maryland Section of the American Chemical Society. He also has been appointed to two American Association of Colleges of Pharmacy (AACP) committees: the Council of

Sections’ Strategic Planning Committee and the Volwiler Research Achievement Award Committee.

Bethany DiPaula, PharmD '95, has been appointed to the American Society of Health-System Pharmacists’ Opioid Taskforce.

Alison Duffy, PharmD, received the Maryland Society of Health-System Pharmacy’s (MSHP) Excellence Award.

Agnes Ann Feemster, PharmD, received MSHP’s Medication Safety Award.

Joga Gobburu, PhD, MBA, has been named a fellow of the American Association of Pharmaceutical Scientists.

Mojdeh Heavner, PharmD ’08, BCPS, BCCCP, has been named a fellow of the American College of Critical Care Medicine.

Jace Jones, PhD, has received a 2020 New Investigator Award from AACP. Lisa Lebovitz, JD, has been appointed to the AACP’s Pharmacy College Admissions Test Advisory Committee and to UMB’s President’s Council for Women.

James Leonard, PharmD, a poison specialist at the Maryland Poison Center, has been named a diplomate of the American Board of Applied Toxicology.

Alexander MacKerell Jr., PhD, received a U.S. patent for “Inhibitors of the Notch Transcriptional Activation Complex and Methods of Use of the Same.”

Mary Lynn McPherson, PharmD ’86, MA, MDE, BCPS, CPE, has been appointed to the Board of Directors of the American Association of Hospice and Palliative Medicine, the first non-physician appointee. She also has been named co-chair of the 2020 International Conference on Opioids.

Ebere Onukwugha, PhD, has been appointed to the state of Maryland’s Prescription Drug Affordability Board.

James Polli, PhD, has been elected president of the Association of Graduate Regulatory Educators.

Brent Reed, PharmD, has been named a fellow of the American College of Clinical Pharmacy.

Kristin Watson, PharmD, has been appointed to the Maryland State Advisory Council on Health and Wellness.

The following School of Pharmacy faculty received promotions: Peter Doshi, PhD – assistant professor of pharmaceutical health services research (PHSR) to associate professor with tenure Agnes Ann Feemster, PharmD – assistant professor of pharmacy practice and science (PPS) to associate professor Emily Heil, PharmD – assistant professor of PPS to associate professor Lisa Jones, PhD –assistant professor of pharmaceutical sciences (PSC) to associate professor with tenure Joey Mattingly, PharmD, PhD – assistant professor of PPS to associate professor of PHSR Kathleen Pincus, PharmD ’09 – assistant professor of PPS to associate professor Jana Shen, PhD – associate professor of PSC with tenure to professor with tenure

Angela Wilks, PhD, has been named chair of the National Institutes of Health’s Prokaryotic Cell and Molecular Biology Study Section for a two-year term.

sp r i ng 2 0 2 0

7

8

c a p su l e

www.pharmacy.umaryland.edu

COMMITTED TO WELL-BEING The School of Pharmacy takes innovative approaches to mental health

By Christianna McCausland

Mental illnesses are common in the United States. According to the National Institute of Mental Health (NIMH), in 2017 there were an estimated 46.6 million adults aged 18 or older with any mental illness (AMI), and 11.2 million with serious mental illness (SMI) wherein the mental, behavioral, or emotional disorder results in serious functional impairment.

While these numbers are high, treatment still lags. NIMH reports that 42.6 percent of those with AMI and 66.7 percent of those with SMI received mental health services within the last year of the reporting. Alarmingly, the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics indicates that rates of suicide in the United States have steadily risen in recent years, up 33 percent from 1999 to 2017.

“The University of Maryland School of Pharmacy has world-renowned experts in the area of mental health, which puts us in a leadership role nationally in terms of education in the areas of mental health,” says Natalie D. Eddington, PhD '89, FAAPS, FCP, dean and professor. “Our School has always seen mental health as a primary focus of the overall health of patients.”

sp r i ng 2 0 2 0

9

The prevalence of mental health issues is hitting close to home, too. In the pharmacy profession specifically, there is a new awareness of the mental health of practitioners and the need to safeguard against burnout. Noting that a survey of health system pharmacists published in 2018 indicated that 53 percent of respondents reported a high degree of burnout, the American Society of Health-System Pharmacists (ASHP) launched a series of efforts and online tools to foster well-being among its members.

Similarly, the American Pharmacists Association (APhA) announced the creation of the Well-Being Index, a screening tool to evaluate fatigue, depression, burnout, anxiety/stress, and mental/physical quality of life. It is just one of APhA’s many efforts to improve the well-being and resiliency of pharmacists and pharmacy personnel.

“There have been so many changes in the work environment that impact pharmacist wellbeing, and the well-being of the provider is so important to offering the best care for the patient,” says Cherokee Layson-Wolf, PharmD '00, CGP, BCACP, FAPhA, associate professor in the Department of Pharmacy Practice and Science (PPS) and associate dean for Cherokee Layson-Wolf student affairs. “Our students get exposure to the pharmacists’ experience through their rotations and learn how to have conversations about [mental health].”

There has never been a more pressing time for the School to continue its role as a leader in mental health education, research, practice, and outreach.

The Mental Health Program

Perhaps the School’s most notable contribution to improving access to mental health care is its Mental Health Program (MHP).

Raymond Love, PharmD ’77, BCPP, FASHP, professor in PPS and director of MHP, recalls the early 1980s, when several of the state of Maryland’s psychiatric and developmental disability facilities were in danger of losing their federal funding due to poor practices in prescribing, dispensing, and monitoring of psychiatric medicines. At the time, Love was director of pharmacy at a facility in Cumberland, Md., and an adjunct faculty member at the School of Pharmacy. Together with William J. Kinnard, PhD, then dean of the School, and the Maryland Department of Health, a memorandum of understanding was created in 1986 for the School

10

c a p su l e

www.pharmacy.umaryland.edu

to provide clinical and administrative pharmacy services at three state facilities.

“We discovered a lack of coordination among the state facilities in terms of formulary and drug use policies, so we moved to a centralized Pharmacy and Therapeutics Committee for the facilities,” says Love. “Once we came in and developed a plan, we were able to turn things around pretty quickly.”

Today, MHP provides services at all five of the state’s adult psychiatric facilities and employs nearly 50 faculty and staff throughout Maryland. MHP’s Raymond Love multiplicity of efforts has introduced innovations into the statewide system including group purchasing programs, dose optimization, coordinated on-call services, and statewide data tracking. It has participated in several research grants and assisted the state with bioterrorism initiatives related to anthrax.

Love explains that the success of MHP and its rapid expansion is rooted in its philosophy that rather than simply fixing a problem, MHP gets to the root of what is causing the issue and builds a solution. For example, MHP did not just fix the state hospital formulary — it examined why there was a problem, articulated a fix, then staffed the solution with the best people.

“Sometimes people ask us a question, but don’t understand what they really need,” says Love. “We help people not only address their problems, we help them build systems.”

Brian Hepburn, MD, executive director of the National Association of State Mental Health Program Directors, worked with MHP in his capacity as medical director for the Mental Hygiene Administration and as the state’s commissioner of mental health, a position he held from 2002 to 2015. He says the contributions made by the School of Pharmacy generally and Love specifically through MHP cannot be overstated.

“The School’s MHP is one of the best I’ve ever seen and without a doubt has improved quality across all the state hospitals,” he states. “And they work closely with medical personnel in the hospitals, so the impact goes beyond the pharmacist.”

Leading at Midtown

One of MHP’s newest programs is located in the psychiatric unit at the University of Maryland Midtown campus, where Megan Ehret, PharmD, associate professor in PPS, is the advanced practice pharmacist. Ehret’s position is so new she’s still evolving her role — the inpatient unit just underwent a complete renovation and the

partial hospitalization unit at Midtown only opened last year. Ehret is a member of the treatment team and also is active in training medical students.

“The pharmacists here [at Midtown] felt that they were going to be asked to provide more services in psychiatry, and they didn’t feel they had the expertise,” Ehret explains. “They reached out to the School for help evaluating what services are needed and to help train their pharmacists to provide those services.”

In addition to her work on inpatient rounding, Ehret has been instrumental in increasing Megan Ehret access to long-acting injectable antipsychotics to patients in need upon their discharge from the hospital. She also is helping the hospital write its policies and procedures for the use of esketamine nasal spray for treatment-resistant depression. Perhaps the most rewarding part of her job is working with trainees.

“Residents and students fresh into this are so eager to learn and be advocates for the patients, which is an important quality in a care provider,” says Ehret. She continues that mental health patients rarely go from unwell to “cured,” and frequently return for services over the life span. “It’s so important to understand this is a returning [patient] population, that we can’t be frustrated by that, and for us to determine how we can best treat them.”

Care for the Developmentally Disabled

Jason Noel, PharmD, associate professor in PPS, also works with a returning patient population through his work in the Mental Health Program. Noel is a pharmacist who practices with the Maryland Developmental Disabilities Administration (DDA), a division of the state Department of Health that cares for more than 16,000 Marylanders with intellectual and developmental disabilities who receive services through a federally funded waiver administered by Medicaid.

According to Noel, “These individuals often present with multiple limitations in intellectual and social functioning and have complex medical issues such as seizure disorders that require medical and pharmaceutical attention.”

Noel takes referrals from community provider agencies of individuals deemed eligible through DDA for him to review their medications and make recommendations. Additionally, Noel

participates in a weekly interdisciplinary clinic at the residential Potomac Center in Hagerstown, Md., reviewing psychotropic medications, patient responses to those medications, and adjusting treatment as needed. He also works on site at the Secure Evaluation and Therapeutic Treatment (SETT) program on the campus of Springfield Hospital Center in Sykesville, Md., where those with intellectual disabilities who have been involved in a crime undergo assessments of competency to stand trial.

Noel explains that while his are some of the most complex patients, access to clinical expertise and different treatment approaches combined with a commitment to not only stabilize patients but also replace self-injurious or difficult behaviors with adaptive behaviors has resulted in success. He’s seen patients who couldn’t leave the house for work become engaged in daily activities and others who have failed multiple community placements find stable Jason Noel residential life.

“In my work we follow people over longer periods of time rather than in an acute psychiatric setting, so we get to see progress,” he says. “There’s not always a straight line from being in crisis to being well, but we are able to see, over a period of time, very dramatic improvements and successes.”

Training the Next Generation of Practitioners

Noel is not only a member of MHP, he is also a graduate of its residency program. Begun in 1987, the ASHP-accredited Psychiatric Pharmacy Practice Residency was the School of Pharmacy’s first residency program. The program is now overseen by another graduate, Bethany DiPaula, PharmD ’95, BCPP, professor in PPS and residency director. The program has trained 34 residents since it began, many of whom go on to leadership positions in pharmacy practice and/or as faculty. Many trainees are retained by the School, thus expanding psychiatric pharmacy services at the University of Maryland, Baltimore.

“We currently have eight board-certified psychiatric pharmacy preceptors associated with our residency program,” says DiPaula.

“Ours is a much larger program than many out there and gives our residents the opportunity to train under psychiatric pharmacists.”

DiPaula’s own work has made important inroads in the treatment

sp ring 2 0 2 0

11

SPOTLIGHT ON RESEARCH A Fast-Acting Antidepressant The National Institute of Mental Health (NIMH) cites depression as the most common mental disorder in the United States. Selective serotonin reuptake inhibitor (SSRI) medications revolutionized treatment for depression, changing the lives of innumerable individuals when they were introduced in the late 1980s.

However, SSRIs do not work for everyone and, more importantly, there is a latency before efficacy is evident, which can be two to four weeks.

“Because SSRIs take a long time to show efficacy we are treating someone and then waiting to find out if our treatment even works,” explains Andrew Coop, PhD, professor in the Department of Pharmaceutical Sciences and associate dean for academic affairs. “Is that the way we should be practicing medicine?”

Coop is part of research underway at the School of Pharmacy that hopes to develop a new antidepressant without the latency period. The NIMH-funded project is a collaboration among the School, Harvard University, University of Texas Health Sciences San Antonio, and the University of Michigan.

Coop explains that there is significant evidence that scopolamine, a drug used to treat motion sickness, can treat depression without the lag time. However, it causes cognitive deficits such as reduced attention and concentration.

“Our research collaborative wants to see if we can develop a similar muscarinic antagonist to scopolamine that retains the antidepressant action without the associated cognitive deficits,” he says.

The work is in the preclinical stage now with a lead compound, CJ2100, a muscarinic antagonist that has proven effective at treating depression in animal models without the long latency period or negative cognitive side effects.

A second compound is in development to enable the research to move to clinical trials.

Coop hopes one day CJ2100 will be the foundation of a medication that can replace SSRIs and bring immediate relief to those with depression.

“Depression is such a debilitating disease,” he says. “We need to reduce the latency period to alleviate the suffering of patients.” b

12

c a p su l e

www.pharmacy.umaryland.edu

of substance use disorder, which often occurs with mental health issues. Most recently, she completed a project funded by the Maryland Department of Health, which educated staff in community pharmacies on opioid use disorder, the overdose medication naloxone, medications available to treat opioid use disorder, and harm reduction strategies. The program reached 136 pharmacies.

Understanding that substance abuse is both a public health issue in the United States as well as a health challenge for individual patients, DiPaula says the School has always been proactive about including substance abuse and mental health in its curriculum.

“From a teaching perspective, even if you don’t think you will be specializing in psychiatry or substance use disorder, you will see patients in primary care or elsewhere who Bethany DiPaula will have psychiatric illness and/or substance use disorders,” she notes.

“It is important to understand that if you’re going to manage the overall health of the patient.”

Mental Health in the Curriculum

Given the breadth of mental health issues and their prevalence, it is no surprise that it is a topic covered in various places throughout the School’s Doctor of Pharmacy (PharmD) curriculum. According to Andrew Coop, PhD, professor in the Department of Pharmaceutical Sciences (PSC) and associate dean for academic affairs, it is embedded in the curriculum like any other disease state. “Mental health education is as important, if not more important, than any other aspect of health,” he says. “It affects so many people that we have always covered mental health in the curriculum.”

First-year students start with a fundamental understanding of the drugs that treat mental health in their Medicinal Chemistry course. In the Applied Sciences and Therapeutics series of courses, an entire module is dedicated to mental health. The topic is revisited again in the final years of the curriculum as part of Pharmacotherapy I and II. While all students are exposed to education in mental health, the elective Perspectives in Mental Health is available for those interested in specializing in the area. Through that course, students gain an understanding of the history of the mental health system, tools and techniques used in the assessment of psychiatric diseases, and current guidelines for psychiatric hospitalization, including civil and criminal commitment. Additionally, the course touches on contemporary issues such as the media’s perception of mental illness and mental health controversies a practicing pharmacist is likely to face.

Andrew Coop

Because mental health is so often intertwined with other health issues, it is embedded in coursework throughout the curriculum.

“If we consider an area such as drug abuse, it is so connected to mental health that when we talk about drug abuse or when we talk about many of the conditions within the curriculum, mental health is always there and is always highlighted as an important component,” explains Coop.

A Healthy Student Experience

Students enjoy learning about mental health and are very engaged in it as part of the curriculum. Yet there can still be stigma associated with mental health challenges within the students’ own lives.

“The academic experience is so different now and the environment is different than in years past,” says Layson-Wolf. “We realize a student’s well-being is strongly tied to their experience at the School.”

Through dialogue with student leaders and in class meetings, students are encouraged to reach out when they are experiencing challenges related to anything, but particularly around matters of mental health. The School’s message is consistent — if someone is struggling or sees a colleague who might be struggling, they are to refer that student to Layson-Wolf or Coop.

“The thing that makes me feel the best about how our students view the concept of mental health isn’t when a student self-identifies that he or she needs help. It’s when a student comes to me and says, ‘My friends told me to come see you,’” says Layson-Wolf. “That shows that friends recognized a change and encouraged that student to reach out.”

In addition to fostering a safe environment where students can ask for help or refer a friend or colleague about whom they might be concerned, the School participates in formal programs to increase awareness of mental health issues and to destigmatize these disorders.

In October, the Student Government Association, in partnership with the National Alliance of Mental Illness (NAMI) and the School’s student chapter of APhA, conducted a week of activities focused on dialogue about mental health. Events were hosted at the University’s SMC Campus Center to reach not only the School’s students but also colleagues in the other professional schools on campus.

Branded with the hashtag #IWillListen, the week included many events like a “Day without Headphones,” to encourage students

to unplug and listen to each other, and a “Healthy Selfie” event to increase the dialogue about constructive ways to use social media.

Students also were encouraged to sign a pledge underscoring why it is important to be compassionate listeners.

All the events were intended to encourage open discussion so students understand it is OK to ask for assistance when it is needed.

In the past, the School’s chapter of the College of Psychiatric and Neurologic Pharmacists has hosted panels where students volunteered to share their mental health history.

“They talked to their colleagues about what that experience was like for them,” says Layson-Wolf. “I was really impressed with the students’ willingness to share because I think that colleague-tocolleague messaging is more meaningful. You see someone who is in the same place in life as you are and what they are going through.”

Layson-Wolf says students are becoming more comfortable having these conversations, reaching out for help, and connecting with resources, like the University’s 24/7 hotline and Counseling Center, where the School has a designated point of contact — Marquette Turner, PhD. “Dr. Turner engages with me on a regular basis to talk about any patterns or issues he sees, while protecting student confidentiality,” Layson-Wolf explains. “It gives us a good connection with the Counseling Center because we have people who are very in tune to our community and the environment at the School of Pharmacy.”

School faculty and staff recently underwent training to learn how to evaluate if a student is in crisis. Called Red Folder training, it was led by the Counseling Center in person at the School during the summer and via webinar in the autumn, with the resources available online for students. The training focuses on an actual Red Folder given to faculty and staff that contains a quick reference guide as well as information on how to recognize symptoms that a student is in distress, appropriate responses based on that assessment, and contact information for therapy or other immediate help.

“As hard as I try, I can’t be everywhere and you never know when a situation may come up. It’s important that faculty and staff not try to navigate this on their own,” explains Layson-Wolf. “The nice thing about the training is it has all the important phone numbers in one place that a faculty or staff member could need to assist a student in crisis. It provides a lifeline for us to make sure we are providing the most appropriate help we possibly can.”

Understanding and contributing to improved mental health, whether that means researching better medications for mental health disorders, working with state agencies to care for vulnerable populations, or providing safe spaces for students to discuss their challenges, will remain an essential part of the School’s mission.

“We pride ourselves on being pre-eminent in our education related to mental health at the School,” says Eddington. “Our mandate moving forward will be to ensure that the School remains a leader in programming and best practices regarding mental health.” b sp ring 2 0 2 0

13

SPOTLIGHT ON RESEARCH Understanding Medication Use in Youth

Susan dosReis, PhD '99, a professor in the Department of Pharmaceutical Health Services Research, has studied pharmacoepidemiology (the utilization and impacts of drugs in population groups) for nearly two decades. Her expertise is in children and adolescents, particularly those served in the public sector by programs like Medicaid. Her current research focus includes using stated preference methods to investigate the benefit-risk tradeoffs that caregivers make when deciding to use a psychotropic medication for their child. She also uses integrated databases to examine the influence of community factors, like crime, poverty, and education, on the safe and effective use of psychotropic medications among children.

dosReis’ research has evolved in tandem with advances in the treatment of mental health disorders in youth. She began her career when stimulant prescribing for young people with ADHD was on the rise. Today, there are not only stimulants approved for use in children but a host of psychotropics and other medications are available. But within that complex landscape, there are disparities. For example, youth in foster care served

by Medicaid have a higher use of these medications.

While there has been a national emphasis on decreasing prescriptions, dosReis notes that it’s important for policy to be informed by data.

“The emphasis is on reducing unnecessary use of medications while

14

c a p su l e

www.pharmacy.umaryland.edu

ensuring that people have access to what they need to manage their condition,” she says.

dosReis also studies the social determinants of health. “The impact I’ve seen from this work is the receptivity in state agencies to use data to inform how well their programs or policies intended to improve mental health outcomes are working and where there are unmet needs,” she states. “I’m excited that these agencies are onboard with incorporating [data] so they can identify children falling through the cracks.”

Researching the rise of stimulant medications being prescribed to young people with ADHD early in her career opened the door to looking at caregiver perceptions of treatment and how that influenced their decision to initiate medication for their child (or to continue it if they did initiate it). At that time, dosReis created a caregiver perception survey called ASK-ME to ascertain caregiver preferences. She has since devised more sophisticated questionnaires that delve deeper into the benefit-torisk threshold for caregivers who must weigh the risk of side effects with the beneficial outcomes for their child that are most important to them.

For example, dosReis just completed a survey of the benefitrisk tradeoffs of antipsychotic use in children and is looking forward to the results, which she anticipates will show not only how caregivers feel about the medication, but what

Susan dosReis side effects the caregiver is willing to tolerate if the tradeoff is that the child can function in school or stay home rather than go to an institution.

“That gives us a lot more information about how individuals differ in their preferences, so we understand not just the [caregiver] attitude but what are the attributes of treatment that affect their decisionmaking,” dosReis says. She adds that the methodology is now expanding to look at how these preferences impact decision-making when evaluating whether treatment is cost effective or not, and which attributes of treatment are most influential in decisionmaking.

This research would not be possible without engaged patients and caregivers. An aspect of dosReis' research is funded by the Patient Centered Outcomes Research Institute.

It provides the “lived experience” that informs the research’s studies and surveys.

“Through that patient-centered work, we’ve created an engaged patient community that feels part of a research team.” b

FACULTY PROFILE

Rave Reviews

BY LOU CORTINA

How do you know you’ve made an impact as a teacher? When students flip the script and take time out of their busy lives to write recommendation letters for you.

This is the case Francis Palumbo with Francis B. Palumbo, PhD, JD, MS, professor in the Department of Pharmaceutical Health Services Research (PHSR) at the School of Pharmacy (SOP). Palumbo was named the University of Maryland, Baltimore’s (UMB) Founders Week 2019 Educator of the Year, with his nomination bolstered by five letters from former students.

And those raves are just the tip of the iceberg for Palumbo, a licensed pharmacist with a PhD in health care administration and a law degree, whose influence on students is expanded by his role as an adjunct professor at UMB’s Francis King Carey School of Law. “If I reached out today to 20 former students — many working for prestigious law firms and at the highest level at the Food and Drug Administration — and asked them to write a testimonial about Dr. Palumbo, they would jump at the chance,” says Virginia Rowthorn, JD, LLM, executive director of UMB’s Center for Global Education Initiatives and a former colleague of Palumbo’s at Carey Law. “He is incredibly warm, welcoming, and delightful.”

Palumbo has been a member of SOP’s faculty since 1974, teaching pharmacy management, medical care organization, health economics, and pharmacy law. In the 1980s, he cofounded the School’s graduate program in pharmaceutical health services research as well as its Center on Drugs and Public Policy, of which he is executive director. He has mentored many master’s and PhD students.

“I am extremely humbled to win the Educator of the Year Award since there are so many extremely talented faculty at

UMB,” Palumbo says. “I have been involved in many aspects of higher education, but my impact on the lives of my students gives me the greatest satisfaction.”

One such former student is Noel E. Wilkin, PhD, provost at the University of Mississippi, who studied under Palumbo at SOP and worked with him while pursuing his PhD in PHSR. “Dr. Palumbo had a memorable influence on my commitment to the pharmacy profession,” Wilkin says. “He combines his legal knowledge and ability as a scholar to make significant contributions in one of the world’s most regulated professions.”

Alan Lyles, ScD, MPH, the Henry A. Rosenberg Professor of Public, Private and Nonprofit Partnerships at the University of Baltimore, is another former student who sees Palumbo as a role model.

“He was an approachable professor and generous with his time,” Lyles says. “Until I took Dr. Palumbo’s courses, I was thoroughly committed to pharmaceutical chemistry. After his courses, I was aware of larger possibilities. I have sought Dr. Palumbo’s counsel throughout graduate school, my years as a medical school administrator, and subsequently in academia. He has set a standard for teaching, learning, and mentorship that I strive to emulate.”

Palumbo has produced countless journal articles, held leadership roles in national organizations, and chaired the Food and Drug Law Journal’s editorial advisory board.

Students at SOP and Carey Law appreciate his deep knowledge of the subject matter, his thoughtful feedback on their papers, and his willingness to go the extra mile to help them with their research. The deans appreciate him, too.

“Dr. Palumbo has applied his pharmaceutical and research training and practice to his academic career and made a great impact on our School and our students,” says Natalie D. Eddington, PhD '89, FAAPS, FCP, dean of SOP. Adds Carey Law Dean Donald B. Tobin, JD, “On our class evaluations, students have praised his mastery of the subject matter, his passion for the material, and his approachability. One student perhaps best captured his persona, describing him as ‘friendly, humble, and smart.’ ” b

sp ring 2 0 2 0

15

STAFF PROFILE

A Steady Source of Support

BY ELIZABETH HEUBECK

Ask anyone who works at a university what they find most rewarding about their job, and the response is likely to center on students: their recruitment, their studies, their post-college landing.

JuliAna Brammer JuliAna Brammer, MBA, considers herself fortunate. As director of admissions, records, and registration for the Doctor of Pharmacy (PharmD) program in the Office of Student Affairs at the School of Pharmacy, she connects with students during each stage of their academic journey.

“It’s always changing. I get to do different things,” Brammer says. Her main priority stays the same, however. “I want students to know that our office supports them,” she says.

According to her supervisor, Brammer also excels at supporting her colleagues. “I rarely hear her say no or see her blink an eye. She is a really valuable member of the team,” says Cherokee Layson-Wolf, PharmD ’00, BCACP, FAPhA, associate dean of student affairs, who lauds Brammer’s “get-it-done” attitude.

Student recruitment for the PharmD program is an integral part of Brammer’s multifaceted job. She and a team of staff and student ambassadors travel to undergraduate institutions from California to Puerto Rico to introduce the School of Pharmacy to prospective students.

Savvy marketing in a fluctuating environment is essential, too. “I need to make sure we’re implementing best practices as quickly as the landscape changes,” Brammer says. While she can’t control factors like changes in demand for pharmacists or the growing number of pharmacy schools nationwide, she can employ multiple recruiting tools to promote the School.

These include outreach activities like attending high school and undergraduate career fairs as well as online and on-campus open houses; creating and disseminating marketing materials; and ensuring that the admissions office is accessible.

Not all of Brammer’s potential recruits are ready to embark on graduate-level coursework. Some aren’t even in high school 16

c a p su l e

www.pharmacy.umaryland.edu

yet. But it’s never too early to learn about a given profession, and Brammer relishes being the one to inform youngsters about pharmacy. “I worked at a nonprofit where I helped young clients with career development and skills training. I really enjoy that piece of what I do,” she says.

Brammer uses creative strategies to introduce local students, mainly those in middle school and high school, to the School. Referred primarily through the University of Maryland, Baltimore's Office of Community Engagement, the young students come to campus and engage in hands-on activities like making lip balm, a fun introduction to the science of compounding pharmacy. They end with a School tour and a visit to the School’s museum, where they peer at pharmacy relics dating back to the 18th century — objects like packaging from diabetic ice cream and cigarettes for asthmatics that make young people appreciate how far the profession has come.

As supervisor of the Office of Student Affairs, where she oversees three staff members and five student employees, Brammer is often the first person to respond to students in need. “If somebody is emotionally in crisis, it takes active listening skills and knowing what resources exist to help them,” Brammer says.

Support goes both ways, she explains. Current PharmD students play an integral role in Student Affairs functions by volunteering at events such as admissions interviews, orientation, and the White Coat Ceremony. “I appreciate their contribution toward our efforts at making incoming students feel welcome,” Brammer says.

Perhaps the most rewarding aspect of her job, reflects Brammer, is witnessing students graduate — a capstone event overseen by Student Affairs. “That’s a really special time, when you see them onstage and you see their families,” Brammer says. “It’s a privilege to be one of the first to welcome students into the School, to support them during their education, then to see them graduate and go on to careers or residencies they have worked so hard to attain.”

When she’s not supporting students, Brammer spends time with her husband, 3-year-old son, and 10-year-old daughter. In her spare time, the die-hard Ravens fan also enjoys yoga, outdoor activities, and traveling. b

STUDENT NEWS

Healthy (and Happy) Halloween Several Student Government Association organizations partnered to host the School’s annual Healthy Halloween for students participating in the University of Maryland, Baltimore’s CURE Scholars Program. b

Members of the Students Promoting Awareness organization, from left: Carla Quinones and Laurie Fontan Cepeda of the Class of 2023; Katherine Owens and Sapna Basappa, Class of 2022; and Alexandra Morris, Class of 2023.

Members of the College of Psychiatric and Neurologic Pharmacists promoted de-stressing with stress balls. From left: A CURE scholar, Zachary Leppert, Anna Rubino, and Rita Chen, all of the Class of 2021.

American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP) members educated CURE students on healthy lifestyle choices and provided healthy snacks for the children. From left: Michelle Nguyen, Class of 2021; Pearl Li and Cradesha Perry, Class of 2023; and Allison Dunn, Emily Mcdougall, and Amy Bao, all of the Class of 2021.

The Pediatric Pharmacy Advocacy Group and APhA-ASP Operation Immunization teamed up to discuss the importance of hand hygiene and hand washing. From left: Brian Sistani and Eun Bi Kim, Class of 2022; Jemini Patel, Class of 2021; Adam Bennett, Class of 2023; and Daniel Trisno, Class of 2022.

sp ring 2 0 2 0

17

STUDENT NEWS

U.S. Public Health Service Information Session

Kappa Psi Steps Out

In September, the School hosted a career information session with representatives from the U.S. Public Health Service (USPHS), where they discussed the Indian Health Service, the USPHS JRCOSTEP/SRCOSTEP Internship program, and student shadowing opportunities at the Centers for Medicare and Medicaid. b

Kappa Psi Sigma chapter members from the Class of 2022 Kristi Adachi, Esther Kim, Minh Ta, Daniel Trisno, and Zaid Rahman volunteered at the Step Out Diabetes Walk in October at the Canton Waterfront Park in Baltimore.

Students at the information session pose with USPHS officers from the U.S. Food and Drug Administration.

APhA-ASP Has a Busy Fall The School’s chapter of the American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP), the largest student government organization at the School, hosted and participated in several events during the fall semester. b

In October, APhA-ASP’s Operation Immunization partnered with Walgreens and the University of Maryland, Baltimore’s (UMB) Health Sciences and Human Services Library to host two flu shot clinics for faculty, staff, and students. During the two-day event, students administered 265 vaccines. Back row, left to right: Xin Gao, Class of 2020; a Notre Dame of Maryland University School of Pharmacy student; Tony Kearney, RPh, of Walgreens; Alexandra Clyde, Class of 2021; Olivia Thomas, Class of 2022; and Griffin Guardala, Class of 2021.

Front row, left to right: Katherine Tieu, Class of 2023; Stella Kim, Class of 2022; and Sachi Patel, Class of 2021.

APhA-ASP members and students from UMB's School of Dentistry and the School of Medicine’s physical therapy program volunteered at the Hollins Health Fair in October to provide free health education to Baltimore residents. Components included a fall risk prevention workshop, flu shot administration, and diabetic foot and blood pressure screenings.

18

c a p su l e

www.pharmacy.umaryland.edu

IPhO Takes a Field Trip Members of the Industry Pharmacists Organization (IPhO) visited AstraZeneca in Gaithersburg, Md., in November. b

Standing from left: Paulina Kepczynska, Adaeze Amaefule, Meghna Bhatt, and Amanda Dinh, all of the Class of 2022. Kneeling and sitting from left: Pavan Patel, Class of 2022; Alexandra Wilson, Class of 2023; Anna Dizik, Class of 2021; Simone Nasroodin, Class of 2023; Yang Lu, and Abel Kwong, Class of 2023.

ASHP on the Road Members of the Student Society of Health-System Pharmacists visited the headquarters of the American Society of Health-System Pharmacists (ASHP) in Bethesda, Md., in October. b

From left: Sean Kim, Class of 2023; Biva Kamal, Class of 2022; Lucia Hwang, Class of 2023; Minlang “Claire” Lin and Drashti Vasaiwala, Class of 2022; and Trexy Palen, Delaney McGuirt, and Jason Van, all of the Class of 2023.

AMCP Hosts Mid-Atlantic Regional Conference The School’s student chapter of the Academy of Managed Care Pharmacy (AMCP) hosted the first Mid-Atlantic Regional Conference in Pharmacy Hall in September. This two-day student-organized conference brought together a large group of aspiring pharmacists from the country’s top PharmD programs to learn from prominent managed care and pharmaceutical industry leaders. b

Conference coordinators from UMSOP, the University of North Carolina, and Rutgers University with Susan Cantrell, RPh, CAE, chief executive officer of AMCP and the conference’s keynote speaker (center in striped sweater).

sp ring 2 0 2 0

19

STUDENT NEWS

White Coat Ceremony Family and friends joined faculty, staff, and alumni of the School of Pharmacy in September to watch as more than 120 student members of the PharmD Class of 2023 donned a pharmacist’s white coat for the first time during the School’s annual White Coat Ceremony for incoming student pharmacists. A tradition in which schools of pharmacy across the country participate each year, the White Coat Ceremony celebrates the start of the class journey as student pharmacists. b

Tecoya Farrakhan, PharmD ’02, MBA, CHC, dispensary manager and clinical director for Curio Wellness, served as guest speaker for the event. Building on the theme of professionalism, Farrakhan shared important lessons learned from her own career with students, underscoring the need for future pharmacists to be able to balance skills with personality, communicate well with others, network at every opportunity, and be open to change.

Students recite the School’s Pledge of Professionalism.

The Class of 2023 20

c a psu l e

www.pharmacy.umaryland.edu

Yijie Cheng receives her white coat from Chanel Whittaker, PharmD, associate professor in the Department of Pharmacy Practice and Science.

Alex Livingston shakes hands with Dean Natalie D. Eddington, PhD ’89, FAAPS, FCP, after receiving his coat.

Strength in Numbers Members of the School’s chapter of the American Society of Consultant Pharmacists (ASCP) attended the organization’s Mid-Atlantic Meeting in Gettysburg, Pa., in August, where students and preceptors from East Coast schools of pharmacy came together for professional development. b

ASCP student members and UMSOP faculty and staff with colleagues from Howard University, Notre Dame of Maryland University, and the University of Maryland, Eastern Shore.

Phi Delta Chi Gives Back

Standing from left: Pinky Shah, Emily Mcdougall, and Michelle Nguyen, Class of 2021; Ryan Mihaly, Stephen Fendt, and Brian Sistani, Class of 2022; Bernard Cabatit, Class of 2020; Maryann Agnello, Andrew Sybing, Eldin Burek, Brady Wilburn, and Nehal Ahmed, all of the Class of 2022; James Mease, Class of 2021; and Jeffrey Banaszak, Garrett Crawford, and Sapna Basappa of the Class of 2022.

Kneeling from left: Lauren Proctor and Hanna Lefebo of the Class of 2022.

Phi Delta Chi (PDC) prides itself on collaboration with local organizations such as the Ronald McDonald House, Hope Lodge, and Paul’s Place. PDC brothers of the School’s Iota chapter spend a large amount of time volunteering. They also contribute to the national Phi Delta Chi Philanthropy that raises money for national pediatric cancer research. A sizable portion of their fundraising profits nationwide are donated to St. Jude Children’s Research Hospital. The Iota chapter’s annual Penny Wars competition took place in November, at which $400 was raised. b

Laurels The School of Pharmacy’s student chapter of the American Association of Pharmaceutical Scientists has been named the association’s 2019 Student Chapter of the Year.

Husam Albarmawi, MS, BPharm, a PhD student in the Department of Pharmaceutical Health Services Research (PHSR), received the department’s Dr. Arthur Schwartz Memorial Scholarship Award.

Meron Assefa, a fourth-year student pharmacist, was a member of the University of Maryland, Baltimore’s (UMB) first place-winning team in the National Academy of Medicine’s Public Health Challenge.

Sharmila Das, a PhD student in the Department of Pharmaceutical Sciences (PSC), received the 2019 Graduate Student Award from the American Association of Indian Pharmaceutical Sciences.

Amy Defnet, a PhD student in PSC, received a Best Poster Award at the International Union of Biochemistry and Molecular Biology meeting in September in Warsaw, Poland.

Bansri Desai, PharmD, a PhD student in PHSR, received the department’s Harris Zuckerman Scholarship.

Third-year student pharmacist Anna Dizik, second-year student pharmacist Andrew Sybing, and first-year student pharmacists

Delaney McGuirt and Alexandra Wilson won the local Pharmacy & Therapeutics Competition of the Academy of Managed Care Pharmacy Foundation.

Arissa Falat, a secondyear student pharmacist, received the Tylenol Future Care Scholarship.

Aakash Gandhi, BPharm, a PhD student in PHSR, received the department’s Student Travel Scholarship. He also won the Best Student Poster Award at the International Society for Pharmacoeconomics and Outcomes Research Europe Meeting in Copenhagen, Denmark, in November.

Rosie Love, MPH, a PhD student in PHSR, received the

department’s Donald O. Fedder Memorial Fellowship.

Jennifer Miller, a fourth-year student pharmacist, received the Phi Lambda Sigma Book Award.

Sharonne Temple, a first-year student pharmacist, received a UMB Center for Global Engagement grant for her project “Examining Barriers to PrEP Use among Adolescent Girls and Young Women in Botswana.”

Sherin Thomas and Dongyue Yu, both PhD students in PSC, received the department’s Dr. Gerald P. and Margaret M. Polli Graduate Student Travel Awards to present posters at the AAPS’ Annual Meeting in November in San Antonio. sp ring 2 0 2 0

21

PRECEPTOR PROFILE

Bursting the Bubble

BY RANDOLPH FILLMORE

Julie Caler

Julie Caler, PharmD ’06, BCGP, BCPS, CPSO, a clinical pharmacist at the Western Maryland Regional Medical Center (WMRMC) in Cumberland, Md., has a philosophy on precepting fourth-year pharmacy students.

“I love teaching and giving students the chance to get out of the ‘academic bubble,’” says Caler, who has been at WMRMC since 2007. “I like to be brutally honest, providing them with real-world experience by showing them the realities of clinical pharmacy and helping them find out if clinical pharmacy is a good fit for them.”

Alex Le, a fourth-year student completing the clinical track at WMRMC, agrees that being face-to-face with patients is quite different from his classroom and textbook work.

“This is a unique and challenging experience,” says Le. “Dr. Caler integrates me into her workflow and challenges me to find my own answers to patient problems. She takes time to discuss each patient, and we figure out how we might modify their medications. She treats me like a colleague.”

As a clinical pharmacist, Caler works closely with patients, many of whom are elderly and rehabbing after fractures or strokes. Medication reconciliation is a priority to ensure medication safety and efficacy as patients transition on and off the unit, she says. Caler also is an instructor for diabetes selfmanagement and assists with antibiotic stewardship.

In her youth, Caler spent a lot of time volunteering in nursing homes in her native Pennsylvania. Eventually, her family relocated to Towson, Md. After several years, Caler returned to Pennsylvania to attend Lehigh University in Bethlehem, where she was a biology major. She entered the University of Maryland School of Pharmacy in 2002 and

22

c a psu l e

www.pharmacy.umaryland.edu

received her PharmD in 2006.

Who were her important mentors at the School?

Nicole Brandt, PharmD '97, MBA, BCPP, CGP, FASCP, professor in the Department of Pharmacy Practice and Science (PPS) and executive director of the Peter Lamy Center on Drug Therapy and Aging, was a key mentor during her training as a student and resident, explains Caler. She also gained critical skills both from the late Fred Abramson, BSP ’56, an assistant professor in PPS who oversaw the pharmacy practice lab, and the late Robert Michocki, PharmD ’75, BCPS, a professor emeritus in PPS. According to Agnes Ann Feemster, PharmD, the School’s assistant dean of experiential learning and an associate professor in PPS, Caler and Western Maryland offer a very different learning environment than urban hospitals in Baltimore, exposing students to pharmacy practice in a rural setting and the unique challenges of the patients who live there.

“As one of the School’s Preceptors of the Year in 2017, Dr. Caler demonstrates a passion for teaching and is vested in developing our students into being independent practitioners,” Feemster says. “Because of her varied practice background, she precepts students for a variety of patient care and non-patient care elective rotations, and many of our required rotation experiences. She invests in each student, tailors each rotation to the needs of the student, and maximizes every learning opportunity.”

When Caler is not working, she enjoys supporting local rescue efforts for animals in the community, through advocacy, fostering, and transporting. b

ALUMNI NEWS

A Message from Alumni Affairs I’m often asked what makes a successful alumni relations program. The question isn’t necessarily what, but who makes an alumni relations program successful. The answer is simple: people. Establishing and maintaining meaningful relationships with our alumni is a key measure of success.

As the pages in this magazine show, we have hosted numerous alumni gatherings and student-led community events in recent months.

It has been wonderful to see so many alumni participate in activities both at the School and at other venues, and especially nice to see many alumni connect back to the School and Greer Griffith with each other for the first time since graduation. Our continued success and growth is dependent upon our alumni’s willingness to give their time, energy, expertise, and resources.

It’s important also to recognize the crucial role that donations play in the School’s drive to maintain excellence. Alumni contributions support faculty research, attract top students, establish scholarships and fellowships, impact national rankings, and build educational programs, such as our new MS in Medical Cannabis Science and Therapeutics. Without these gifts, it would be difficult for the School to maintain the exceptional education, practice, research, and community programs for which we are known.

Gifts come in many forms, but a successful alumni relations program relies on one very important gift: the gift of time.

Alumni relations programs strive to build, strengthen, and sustain relationships with the alumni community. Success in building that community is dependent on your participation. The more alumni who become involved, the more robust and valuable our alumni network becomes.

Alumni who volunteer their time to speak to our students, attend events, recruit future students, participate on alumni boards, or volunteer for School of Pharmacy initiatives contribute immeasurably to our success. Alumni are our greatest voice, and we rely on you to serve as advocates for the School.

Thank you to all our alumni for your continued support, engagement, and advocacy.

Gratefully, Greer Griffith, MS Director of Alumni Relations and Annual Giving Office of Development and Alumni Affairs P.S. Please feel free to reach out if you are interested in becoming more involved with the School. You can contact me at ggriffith@rx.umaryland.edu.

Alumni Association Executive Committee 2019-2020 Kelcymarie Bye, PharmD ’16 President

Geoffrey Heinzl, PhD ’16 Secretary

Michael Beatrice, PhD ’01

Kristine Parbuoni, PharmD ’05 President-elect

David Ngo, PharmD ’13 Treasurer

Denise Fu, PharmD ’10

Robyn Firmin, PharmD ’17 Past president

Capt. James Bresette, PharmD ’97 C. Lawrence Hogue, BSP ’69 Aicha Moutanni, MS ’17 Magaly Rodriguez de Bittner, PharmD ’83 Marci Straus, PharmD ’12

sp ring 2 0 2 0

23

ALUMNI NEWS

Class Notes 1953

1997

2013

Philip Karn, BSP, has been living at Roland Park Place senior living community in Baltimore for more than four years. He would like to chat with any member of the Class of 1953. Please contact the Office of Development and Alumni Affairs at alumni@rx.umaryland. edu for his phone number and email address.

Tony Guerra, PharmD, received the Phi Delta Chi 2019 Selfless Servant Award, which recognizes alumni who have gone above and beyond to give back and serve the fraternity.

Kashelle Lockman, PharmD, was recognized by the University of Iowa College of Pharmacy’s Class of 2021 as its Teacher of the Year. She also received the American College of Clinical Pharmacy’s 2019 New Educator Award.

1968 Arnold Honkofsky, BSP, was featured in The Baltimore Sun in September 2019 for his volunteer work with Greater Baltimore Medical Center’s (GBMC) signature event, the Legacy Chase at Shawan Downs. The event, which includes steeplechase horse races and food trucks, benefits oncology services and patient support programs at GBMC. The article also highlighted Honkofsky’s support for Death With Dignity legislation.

1984 Matthew Shimoda, PharmD, recently joined the Notre Dame of Maryland University School of Pharmacy as its assistant dean of student affairs.

1989 Kim D. Tanzer, BSP, was appointed president of the Massachusetts Board of Registration in Pharmacy.

1998 Kimberly Couch, PharmD, and her husband, Paul, are the proud parents of son Gregory, age 14, who is celebrating three years as a founding member of the Maryland MidShore Chapter of Project Linus, a national nonprofit organization that provides new, handmade blankets for children in need. Gregory and Kimberly have donated 750 quilts, afghans, and fleece blankets to children in need in the MidShore area.

2006 Joseph LaRochelle, PharmD, received the Phi Delta Chi 2019 Selfless Servant Award, which recognizes alumni who have gone above and beyond to give back and serve the fraternity.

We want to know what’s happening with you!

Please send us updates on your personal and professional life. Have you changed jobs, had a recent promotion, received an honor or appointment? Did you recently get married or celebrate the birth of a child or a grandchild? Do you have an interesting hobby or participate in community service projects?

Please let us know by completing the School of Pharmacy’s online Class Notes form at www.pharmacy.umaryland.edu/ alumni/resources/class-notes/.

2008 Jamie Wilkins, PharmD, and Laura Zendel, PharmD, received the U.S. Food and Drug Administration’s Frances O. Kelsey Drug Safety Award for their development and review of the Palynziq REMS.

In Memoriam The University of Maryland School of Pharmacy honors the lives and memories of the following alumni who passed away between Jan. 1, 2019, and July 1, 2019. We are grateful to each of these alumni for the lasting impact that they made on the School community and the advances they achieved in pharmacy education, research, or practice.

Alfred Abramson, BSP ’56 Kenneth S. Bauer Jr., BSP ’89 Richard J. Brodeur, MS ’65 David C. Clarke, BSP ’52 Betty W. Cohen, BSP ’49 Barry A. Edelman, BSP ’69

Richard M. Goodman, BSP ’67 Marvin B. Jaslow, BSP ’58 Beryl Lerner, BSP ’61 Howard E. Mandel, BSP ’50 Annette Padussis, BSP ’82 Irving J. Raksin, BSP ’60

Stanley Scherr, BSP ’54 James B. Walter Jr., BSP ’51 Milton M. Waxman, BSP ’38 Morton H. Weiner, BSP ’50

If you would like to make a memorial gift, please use the enclosed giving envelope or call 410-706-5893.

24

c a psu l e

www.pharmacy.umaryland.edu

PSC Grad Gathering The Department of Pharmaceutical Sciences (PSC) hosted its third biennial PSC and Regulatory Science Grad Gathering at the School of Pharmacy in September. Organized by the PhD in PSC, the MS in PSC, and the MS in Regulatory Science programs, the daylong event featured a wide range of activities designed to foster networking and professional development among attendees. b

From left: PSC graduate students Alecia Dent and Ramon Martinez; Paul Shapiro, PhD, professor and chair of PSC; and Katherine Joyner, PhD ’13.

From left: Balvinder Vig, PhD '01; Aaron Smith, PhD ’15; Angela Wilks, PhD, the Isaac E. Emerson Chair of Pharmaceutical Sciences; and Steven Fletcher, PhD, associate professor in PSC.

Angela Wilks moderates a panel with alumni, from left, Pallavi Nithyanandan, PhD ’05; Heather Boyce, PhD ’17; Brittany Avaritt, PhD ’14; Maura O’Neill, PhD ’13, and Daniel DeCiero, MS ’18.

Attendees enjoyed a happy hour at the Union Wharf Clubroom at the end of the day.

Ritu Lal, PhD ’96, MS, chief executive officer and co-founder of GEn1E Lifesciences, delivered the keynote address.

ASHP Mid-Year Alumni and Friends Reception More than 200 alumni, faculty, staff, residents, and students attended the School’s reception at the American Society of Health-System Pharmacists (ASHP) Mid-Year Meeting in Las Vegas in early December at the Mandalay From left: Lynette Bradley-Baker, BSP ’92, PhD ’99; Anthony Guerra, PharmD ’97; Bay Resort and Casino. b

Soumi Saha, PharmD ’07; Michelle Rager, PharmD ’07; Steven Allison, PharmD ’06; Kristine Parbuoni, PharmD ’05, associate professor of pharmacy practice and science; and Karla Evans, BSP ’93.

sp ring 2 0 2 0

25

Q&A with Alumni Association Secretary Geoffrey Heinzl, PhD ’16

Geoffrey Heinzl

Where are you from?

I am originally from Pittsburgh. I attended Allegheny College, where I double-majored in chemistry and French before moving to Baltimore for my graduate studies.

Why did you choose the University of Maryland School of Pharmacy?

When searching for graduate programs, I wanted to find a school where the study of medicinal chemistry was more than applied organic chemistry. I searched for a collaborative, holistic view of drug discovery and was delighted to find it here in the Department of Pharmaceutical Sciences. The coordinated approach to research was immediately evident during my interview at the School, and I left hoping that I would get the opportunity to experience it firsthand.

Where do you work and what do you do there?

I am a biomedical life scientist at Leidos, Inc., supporting the Congressionally Directed Medical Research Programs in the Department of Defense. I serve as the scientific manager for the Military Operational Medicine Research Program and the newly founded Chronic Pain Management Research Program.

I coordinate and facilitate programmatic review meetings, in-progress review meetings, and other review meetings as needed for the execution of Congressional Special Interest programs and other military biomedical research programs.

What inspired you on this career path?

Looking back at my time in graduate school, I realized that my favorite days were filled with activities that I performed as

26 26

c caapsu p sullee

www.pharmacy.umaryland.edu www.pharmacy.umaryland.edu

part of various student government organizations [including serving as president of the University of Maryland, Baltimore Student Government Association]. I felt like I was making an impact on the School and improving the student experience.

I decided that I wanted a career that empowers scientists and researchers. To that end, I was excited to find an opportunity working in the research funding process, with the hope of eventually finding my way into the field of science policy. I want future researchers to feel supported and inspired, not fearful of dwindling funding and cumbersome administrative processes, so I’m dedicating myself to creating that future.

Why are you involved with the School’s Alumni Association?

The Alumni Association offers a great resource for all of the School’s students and alumni, but accessibility can seem limited or the resources less applicable to students not pursuing a PharmD degree. I want to represent the School’s other students and alumni, including PhD and MS degreeseekers, and ensure that the Alumni Association makes its resources applicable and available to all of the School’s students and alumni.

What advice do you have for your fellow alumni regarding staying connected to the School?

Staying connected to the School is as easy as staying connected with our fellow alumni. We’re our own best resources, and we can be found all over the state and beyond.

Keep us in mind when opportunities become available, and we’ll do the same for you.

ALUMNI PROFILE

Making the Most Out of a Tight Schedule

BY ELIZABETH HEUBECK

Mena Gaballah, PharmD ’18, JD ’18, knows a thing or two about time management. Gaballah, an intellectual property and health care associate at the law firm Crowell & Moring, LLP, graduated Mena Gaballah from the School of Pharmacy in 2018. That same year, he also earned a degree from the University of Maryland Francis King Carey School of Law. It’s hard to fathom the intense schedule required to obtain a law degree and a pharmacy degree simultaneously, let alone actually pursue it. But Gaballah seems to have taken it in stride.

What’s more, he humbly credits faculty at both schools with making the intense schedule work. “While it was tough, it was manageable. People who were understanding made things a lot easier,” says Gaballah, who intentionally pursued the dual degree in order to be able to use a clinical and scientific background in the practice of law. He points to Cherokee Layson-Wolf, PharmD ’00, CGP, BCACP, FAPhA, the School of Pharmacy’s associate dean for student affairs, as a faculty member key to his success.

According to Layson-Wolf, Gaballah’s somewhat rare academic circumstances coupled with his proactive nature turned out to be mutually beneficial. One of the first students she advised through the dual degree, Gaballah provided Layson-Wolf with an insider’s perspective of the challenges it presented. Together, they met regularly with Crystal Edwards, JD, MA, assistant dean for academic affairs at Maryland Carey Law. “These exchanges helped inform our interactions with other dual-degree students,” Layson-Wolf observes.

While coordination of academic scheduling between the two schools helped Gaballah flourish in the classroom, he also made time as a dual-degree student to pursue several beneficial

extracurricular experiences. As a first-year pharmacy student, he competed in the National Community Pharmacist Business Plan Competition. Over several months, he and three other students developed an opioid and controlled substance insurance plan.

Gaballah also co-authored an opinion piece in The Baltimore Sun calling for tighter regulation of improperly used over-thecounter substances. Co-authors included Neal Reynolds, MD, co-director of the Multi-Trauma Intensive Care Unit at the R Adams Cowley Shock Trauma Center, and Thomas Scalea, MD, FACS, FCCM, physician-in-chief at Shock Trauma.

Authoring this timely essay alongside key members of Shock Trauma’s leadership team speaks to Gaballah’s maturity as a student. It also demonstrates the profound influence that his fourth-year critical care rotation at the R Adams Cowley Shock Trauma Center had on his overall experience as a pharmacy student. He points to attending pre-rounds, seeing very complicated multi-trauma patients, and collaborating with the medical team as some of the highlights of his academic career.

But it wasn’t just the clinical rotation’s intense, adrenalineboosting nature that broadened Gaballah’s knowledge base — and prepared him for the future. After completing 10- to 12-hour days at Shock Trauma, Gaballah would head straight to the law school for classes. The demanding pace challenged his stamina.

But a breakneck schedule seems to have become Gaballah’s norm. In his first postgraduate job as a lawyer providing fullservice intellectual counseling services to a range of clients — including pharmaceutical, chemistry, biotechnology, and materials science technologies — Gaballah has little downtime.

“It can be fairly intense,” he says of working on several different projects simultaneously. But it’s a path he’s happy he chose.

“My PharmD was integral to both landing and excelling at my job. Having a strong clinical and scientific background allows me to grasp concepts quickly and put to use what I learned in pharmacy school,” Gaballah says. b

sp ring 2 0 2 0

27

In Service to Others All of us are influenced by the events and experiences in our lives.

When we received an email about an alumnus of ours, we decided to share his unique story, which captures this essence.

Herbert Friedman

Herbert Friedman, BSP ’50, was born in Vienna, Austria, in December 1924. In 1938, with the threat of war looming and being of Jewish heritage, he escaped from Vienna at the age of 14 onboard a children’s train bound for England. A year prior, Mr. Friedman and a friend were on their way home when they spotted a girl struggling to swim in the Danube River. They quickly jumped into the river and saved her life.

Their actions earned them notoriety in the local newspaper and in turn helped Mr. Friedman escape from Austria and ultimately the Holocaust.

After living in an orphanage in England, Mr. Friedman landed in Baltimore through the aid of a sponsor. He attended Forest Park High School before enrolling in the University of Maryland School of Pharmacy, where he was a member of the Rho Chi Honor Society.

The spirit of helping others did not end with him saving the girl from the river in 1937. In fact, Mr. Friedman has spent the rest of his life helping others. Upon graduation, he began working at Read’s Drug Store on Gay Street.

With a desire to serve his new country, he joined the

28

c a p su l e

www.pharmacy.umaryland.edu

Army, becoming a medic in the Pacific during World War II and overseeing the hospital pharmacy at Fort Lee, Va., during the Korean War.

Following his military service, Mr. Friedman owned a pharmacy in Chesapeake, Va. He and his wife of more than 68 years, Joyce, owned and operated Portlock Pharmacy for more than 30 years. His three children worked at the pharmacy’s soda fountain and made deliveries to customers. The Portlock Pharmacy was a place to gather. A place to sit and talk. And, of course, a place to meet and be helped by “Doc” Friedman. Mr. Friedman was at his happiest while working at the pharmacy.

Following his retirement, Mr. Friedman returned to work at the Naval Pharmacy in Norfolk, Va., before returning home to Baltimore where he has lived since, always feeling a great debt to the country that welcomed him, and to those who provided him an education and a means of making a living. Now 95, he has always loved pharmacy and the opportunity to serve. b

DONOR PROFILE

Loyal to Students Even in Retirement

BY GWEN NEWMAN

Bob and Kathy Beardsley

For 42 years, Robert Beardsley, PhD, has played a pivotal role at the School of Pharmacy. A practicing pharmacist turned educator, mentor, and advocate for the profession, Beardsley has had quite a career. He is the recipient of more than a dozen prestigious awards, has developed that many courses in the School’s Doctor of Pharmacy (PharmD) program, and has helped create its dualdegree programs. He authored a textbook — Communication Skills in Pharmacy Practice — now in its seventh edition that sells about 4,000 copies each year worldwide, has advised and mentored hundreds of students, and was three times named Teacher of the Year by the School’s graduating PharmD class.

It’s little surprise then that after a career of such distinction, Beardsley chooses to give in a way that greatly impacts students.

He and his wife, Katherine Pedro Beardsley, PhD, former associate dean at the University of Maryland, College Park’s (UMCP) College of Behavioral and Social Sciences (BSOS), have endowed five annual scholarships — at the School of Pharmacy, UMCP, and Oregon State University (OSU), their shared alma mater. At the School of Pharmacy, the Beardsleys’ endowed scholarship helps students financially while preparing for their future careers.

That was important to the couple. The Beardsleys met on the OSU campus in the late 1960s while in the marching band.

They have marched in step ever since. Known for hosting departmental events at their home in Ellicott City, he invests time and energy into do-it-yourself home improvement projects.

She continues to serve on the board of visitors for UMCP’s BSOS. They are parents to son Kyle, now a professor of political science at Duke University. Education is in the family blood, and Beardsley says the couple is now happy to help others.

“Many individuals supported us as well as our son both financially and as mentors,” he said. “We felt it important to do the same.”

The School is honored by their support and dedication.

“I knew of Bob’s renown prior to joining the School of

Pharmacy five years ago and have been privileged to work with him,” says Ken Boyden, JD, EdD, associate dean of development and alumni affairs. “From day one, I’ve been extraordinarily impressed with his service to the School — updating the Strategic Plan, leading committees, how the needs of students always come first. He and Kathy have put that sentiment into action through their scholarship.”

A 1972 graduate of OSU, Beardsley then earned a master’s and a PhD, both from the University of Minnesota. He spent several years working in a U.S. Public Health Service hospital in New Orleans, then shifted into the academic arena — a natural move given his love of teaching combined with research.

Beardsley joined the School of Pharmacy in 1977, rising from assistant professor to associate dean for student affairs.

He also served as vice chair for education and vice chair for administration in the Department of Pharmaceutical Health Services Research. His final title is professor emeritus, an honor bestowed upon select faculty as they retire, which Beardsley did in December 2019.

Among the many awards and accolades he has received, Beardsley says he was most honored to receive the American Association of Colleges of Pharmacy’s (AACP) Distinguished Educator Award and the University of Maryland, Baltimore’s Diversity Recognition Award. He served two terms on the board of AACP and spent six years (two as president) on the board of the Accreditation Council for Pharmacy Education (ACPE). He facilitated the formation of the Maryland Pharmacy Coalition, helped found Hospice Services of Howard County, and is currently teaching within the American College of Clinical Pharmacy’s Leadership Academy.

In retirement, he plans to continue his work in pharmacy education by working with ACPE’s international services program to assist other countries improve how they educate their pharmacists. b sp ring 2 0 2 0

29

RESIDENT PROFILE

A Change for Better

BY LYDIA LEVIS BLOCH

Inspired by his pediatrician father, Sandeep Devabhakthuni, PharmD, BCCP, intended to become a physician. During his senior year of college, Sandeep Devabhakthuni though, he realized he no longer was passionate about medicine.

Following an experience studying HIV medications, Devabhakthuni determined he wanted to help patients with their medication regimens. “I became a pharmacist to have an impact on medication use,” he says.

After earning a Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy, Devabhakthuni undertook a life-altering pharmacy practice residency at the University of Maryland Medical Center (UMMC) in 2009.

He then completed a second postgraduate residency back in Pittsburgh in cardiology and critical care. In 2011, he returned to Baltimore, this time as an assistant professor at the University of Maryland School of Pharmacy.

“Why did I return?” Devabhakthuni asks. “I was really impressed by the University of Maryland when I did my first residency and appreciated the mentorship I received, in particular from Dr. Watson,” he says, referring to Kristin Watson, PharmD, BCCP, associate professor in the Department of Pharmacy Practice and Science (PPS) and the department’s vice chair for clinical services. “She is still my mentor today,” he adds.

Now Devabhakthuni is an associate professor in PPS and is director of the School’s residency and fellowship program, the very program in which he participated as a resident in 2009.

The program, a partnership between the School of Pharmacy and UMMC, accepts recent PharmD graduates from any school or college of pharmacy for a one- or two-year residency or

30

c a p su l e

www.pharmacy.umaryland.edu

fellowship position. Residents specialize in pharmacy practice areas such as toxicology, pediatrics, pharmacotherapy, critical care, and ambulatory care, receiving the additional training and education they need to practice more direct patient care. The program offers 14 specialties for residents and four for fellows.

Nationwide, there are only a few schools of pharmacy offering as extensive a program as the one Devabhakthuni directs.

Since 2016, a total of 44 residents and fellows have completed the program. Currently, 26 are enrolled. Upon completion, about two-thirds of the residents opt to work in a clinical setting, while one-third embark on careers in academia.

Devabhakthuni estimates he has personally trained approximately 50 residents and fellows. “It’s fun to see the trainees’ faces light up when they grasp a concept, and it’s rewarding to know that I’m influencing a future generation of pharmacists who will make their patients’ lives better,” he says.

Devabhakthuni’s enthusiasm for teaching and learning has not gone unrecognized. He has amassed awards such as the Class of 2018’s Faculty Member of the Year, 2016 University of Maryland Residency and Fellowship Preceptor of the Year, and Maryland Society of Health-System Pharmacy’s 2013 Pharmacist of the Year.

In addition to his oversight of the residency and fellowship program, Devabhakthuni teaches in the School’s Doctor of Pharmacy program, serves as a preceptor for student pharmacists on rotations, and is a board-certified cardiology specialist practicing in the inpatient cardiology service and outpatient heart transplant clinic at UMMC. His research focuses on appropriate use of cardiovascular medications and sedation in mechanically ventilated patients.

For relaxation, Devabhakthuni, who is from West Virginia, can be found outdoors hiking mountains or traveling. His most recent adventures took him to Costa Rica and India, but for him, Baltimore is home. b

2017-2018 ANNUAL REPORT

sp ring 2 0 2 0

31

LEADERSHIP

LEADERSHIP

Dean Natalie D. Eddington, PhD, FAAPS, FCP Senior Associate Dean for Administration and Finance William J. Cooper, MBA Associate Dean for Academic Affairs Andrew Coop, PhD Associate Dean for Clinical Services and Practice Transformation Magaly Rodriguez de Bitttner, PharmD, BCPS, CDE, FAPhA

Chair, Department of Pharmaceutical Sciences Paul Shapiro, PhD Chair, Department of Pharmacy Practice and Science Jill Morgan, PharmD, BCPS, BCPPS

BOARD OF VISITORS

Stephen J. Allen, RPh, MS ’78, FASHP, Chair Former CEO, American Society of HealthSystem Pharmacists Foundation Barbara M. Alving, MD, MACP Professor of Medicine, Uniformed Services University of the Health Sciences Research Professor, School of Public Health, University of Maryland, College Park

CENTERS

Bio- and Nano-techology Center Bruce Yu, PhD, Director

John Banta, MBA Managing Director BlueCross BlueShield Venture Partners

Associate Dean for Development and Alumni Affairs Ken Boyden, JD, EdD

Center for Innovative Pharmacy Solutions Magaly Rodriguez de Bittner, PharmD, BCPS, CDE, FAPhA, Executive Director

Harold E. Chappelear, DSC ’98, RPh, LLD (Hon.) Principal, InternaSource, LLC

Associate Dean for Graduate Programs Sarah Michel, PhD

Center for Translational Medicine Joga Gobburu, PhD, MBA, FCP, Director

Associate Dean for Research and Advanced Graduate Studies Peter Swaan, PhD

Center of Excellence in Regulatory Science and Innovation James Polli, PhD, Co-director

Victoria G. Hale, BSP ’83, PhD, DSc (Hon) Founder & Former CEO OneWorld Health Medicines360

Associate Dean for Student Affairs Cherokee Layson-Wolf, PharmD, CGP, BCACP, FAPhA

Center on Drugs and Public Policy Francis B. Palumbo, PhD, JD, Executive Director

Assistant Dean for Academic Affairs and Assessment Lisa Lebovitz, JD

Computer-Aided Drug Design Center Alexander D. MacKerell Jr., PhD, Director Jana Shen, PhD, Co-director

Assistant Dean for Communications and Marketing Rebecca Ceraul

Maryland Poison Center Bruce D. Anderson, PharmD, Director

Assistant Dean for Experiential Learning Agnes Ann Feemster, PharmD, BCPS Assistant Dean for Information Technology Tim Munn Assistant Dean for Instructional Design and Technology Shannon Tucker, MS

32

Chair, Department of Pharmaceutical Health Services Research C. Daniel Mullins, PhD

Mass Spectrometry Center Maureen Kane, PhD, Executive Director Mental Health Program Raymond Love, PharmD, Director Metallotherapeutics Research Center Sarah Michel, PhD, Co-director Angela Wilks, PhD, Co-director

Assistant Dean for Policy and Planning Deborah Dewitt, JD

Peter Lamy Center on Drug Therapy and Aging Nicole Brandt, PharmD, MBA, BCPP, CGP, FASCP, Executive Director

Assistant Dean for the Universities at Shady Grove Heather Brennan Congdon, PharmD, CACP, CDE

Pharmaceutical Research Computing Ebere Onukwugha, PhD, MS, Executive Director

c a p su l e

www.pharmacy.umaryland.edu

Gina McKnight-Smith, PharmD ’97, MBA, CGP, BCPS Regional (Mid-Atlantic) Medical Outcomes Science Liaison AbbVie, Inc. Thomas E. Menighan, BSPharm, MBA, FAPhA Executive Vice President and CEO American Pharmacists Association David W. Miller, PhD ’93 Operating Partner, GHO Capital Ltd. Jane Shaab, MBA Senior Vice President and Executive Director, University of Maryland BioPark Assistant Vice President for Economic Development, University of Maryland, Baltimore Jermaine Smith, RPh Senior Director, Legislative and Regulatory Affairs Rite Aid Pharmacy Ellen H. Yankellow, PharmD ’96, BSP ’73 President and CEO, Correct Rx Pharmacy Services, Inc.

Special thanks to the following contributors: William Cooper, Nicole Derr, Jenny Giller, Greer Griffith, Cherokee Layson-Wolf, and Lisa Lebovitz

KEY FACTS

ACADEMIC PROGRAMS 881

Total enrollment all degree programs

ACADEMIC TRAINING 37

Postdoctoral fellows

22 Residents PHARMD PROGRAM 535

Total enrollment

FACULTY

Fall 2018 admission

90

Full-time faculty

632

Total applicants

115

Affiliate faculty

131

Entering class

698

Preceptor faculty

21%

Acceptance rate

73%

With undergraduate degree or higher

STAFF

3.37

Average incoming GPA

70

Administrative, business, development and alumni

75%

Average PCAT composite percentile rank

affairs, experiential learning, human resources,

communications and marketing, student affairs,

and faculty support

30% White

233

Technical, research staff, postdoctoral fellows,

20% Black

and teaching assistants

Ethnicity across all four years: 39% Asian

5% Hispanic 3% International

SCHOLARLY ACTIVITY

2% Multi-ethnic

144

Principal investigators

1%

419

Refereed works published (authored or co-authored)

129

Non-refereed works published (authored or

No response

Number may not total 100 percent due to rounding

co-authored) PHD PROGRAMS 88

Total enrollment

Department of Pharmaceutical Health Services Research 26 Students

598

Papers presented at professional meetings

PROFESSIONAL SERVICES 16

Review panels (off-campus peer review panels and

accreditation and certification teams)

2,537

Manuscripts read/reviewed for professional journals,

Department of Pharmaceutical Sciences

conferences, and publishers

62 Students

74

Editors/associate editors for professional journals

79

Officeholders of professional associations

MASTER’S PROGRAMS

197

Total days in public service (non-consulting role with

258

K-12 schools and community colleges, government

agencies, nonprofit organizations, or businesses)

Total enrollment

Pharmaceutical Health Services Research 3

Students

Palliative Care 139

Students

PLACEMENT/EMPLOYMENT Job Placements for the PharmD Class of 2018 Data is based on a survey voluntarily completed by graduating students in May.

Pharmaceutical Sciences 6

Students

152

Total Number of Graduates

53

Additional Training (PGY1, Fellowship,

Graduate School)

42

Community Pharmacy, Chain or Independent

Regulatory Science

3

Hospital Pharmacy or Outpatient Health System

56

4

Other (Pharmacy LTC, USPHS, Industry, Federal, etc.)

50

Did Not Respond to Survey or Still Seeking

Pharmacometrics 54

Students

Students

Employment

sp ring 2 0 2 0

33

FINANCIALS

SOURCES OF OPERATING REVENUES SUPPORTING THE SCHOOL This report is an unaudited presentation of revenues supporting the School.

Gifts $2,857,660 Grant and Contract Awards and Designated Research Initiative Funds $31,009,213

FISCAL YEAR 2017-2018 Total Source of Funds $68,592,812 Net General Appropriation and Tuition and Fees $29,852,573

Auxiliary and Misc. $2,934,564

Scholarships, Fellowships, and Endowments $1,571,486

Federal Funds $367,316

Gifts $1,354,592

FISCAL YEAR 2016-2017 Total Source of Funds $64,974,543

Grant and Contract Awards and Designated Research Initiative Funds $29,404,062

Net General Appropriation and Tuition and Fees $28,978,016

Auxiliary and Misc. $3,238,792 Federal Funds $367,316

34

c a p su l e

www.pharmacy.umaryland.edu

Scholarships, Fellowships, and Endowments $1,631,764

NEW FACULTY

Daniel Deredge, PhD Research Assistant Professor Department of Pharmaceutical Sciences Born in France, Deredge grew up primarily in Ethiopia where he completed his high school education. In 1999, he came to the United States to attend Louisiana State University in Baton Rouge, where he received both a Bachelor of Science and a PhD in biochemistry. During his graduate studies, Deredge characterized the solution thermodynamic properties of DNA binding by bacterial DNA polymerase I, focusing specifically on the polymerase from E. coli and T. aquaticus and their response to the accumulation of the physiological counter-anion glutamate. Subsequently, Deredge undertook postdoctoral studies at Case Western Reserve University in Cleveland, where he studied the structural origin of resistance of HIV reverse transcriptase to a non-nucleoside reverse transcriptase inhibitor, Efavirenz, applying hydrogen-deuterium exchange coupled with mass spectrometry (HDX-MS). In 2012, he came to the University of Maryland School of Pharmacy to pursue additional postdoctoral training and, as part of the School’s Mass Spectrometry Center, expand the application of HDX-MS, native mass spectrometry and ion mobility, fast photochemical oxidation of proteins to various biological and biophysical systems. His studies include bacterial, viral, and human protein systems studied within the perspective of protein folding, protein dynamics, protein-ligand binding, protein-protein interactions, and protein-nucleic acids interactions. As a research assistant professor, Deredge is developing and applying a framework to correlate experimental HDX-MS with computational approaches to augment the structural and biophysical understanding of various systems.

Ashlee Mattingly, PharmD, BCPS Assistant Professor Department of Pharmacy Practice and Science Mattingly received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy in 2011. After graduation, she worked as a pharmacist at Kindred Hospital, a long-term acute care hospital, in Louisville, Ky. In 2013, Mattingly joined Community Hospital South in Indianapolis as a clinical pharmacist. At the University of Maryland School of Pharmacy, Mattingly focuses on sterile and non-sterile compounding and serves as director of the School’s PharmTechX Program, an advanced pharmacy technician

training program. Her research includes the advancement in delivery of patient care through the use of pharmacy technicians, including the potential opportunities and the positive impact this can have on patient outcomes and overall pharmacy technician satisfaction. She also is interested in the regulations surrounding sterile and nonsterile compounding and developing processes that balance public safety with the efficient production of compounded pharmaceutical products. Mattingly has two research grants with the U.S. Food and Drug Administration evaluating the use of bulk drug substances in compounding as outlined in the Drug Quality and Security Act passed in 2013.

Kristine Parbuoni, PharmD, BCPPS Associate Professor Department of Pharmacy Practice and Science Parbuoni obtained her Doctor of Pharmacy from the University of Maryland School of Pharmacy in 2005. She then completed a PGY1 pharmacy residency and PGY2 pediatric residency at Johns Hopkins Hospital in Baltimore. Following residency training, Parbuoni became the clinical pharmacy specialist in the Pediatric Intensive Care Unit at the University of Maryland Children’s Hospital, where she later also took on administrative roles.

Parbuoni then joined the faculty at Loma Linda University School of Pharmacy as an assistant professor in the Department of Pharmacy Practice, where she was also director of the PGY2 Pediatric Residency Program. She is a board-certified pediatric pharmacy specialist and maintains a clinical practice site in general pediatrics at the University of Maryland Children’s Hospital. She is also director of the School of Pharmacy’s PGY2 Pediatric Residency. Parbuoni has been actively involved in professional organizations throughout her career. She has served as president of the Maryland Society of Health-System Pharmacy, as a delegate for the American Society of Health-System Pharmacists (ASHP), on ASHP’s Council on Education and Workforce Development and Preceptor Development Section Advisory Group (SAG) and Pediatrics SAG. Parbuoni also was chair of the California Society of Health-System Pharmacists Membership Committee and chair of the Research Committee of the Pediatric Pharmacy Association. Her research interests include clinical outcomes in pediatrics (infectious diseases, critical care), pediatric pharmacokinetics, educational methods and outcomes in simulation, and postgraduate training.

sp ring 2 0 2 0

35

NEW FACULTY

Ryan Pearson, PhD Assistant Professor Department of Pharmaceutical Sciences

Zafar Zafari, PhD, MSc, BSc Assistant Professor Department of Pharmaceutical Health Services Research

Pearson’s research focuses on engineering nanoparticles to achieve programmable immune responses for specific immunomodulation and molecular design to achieve controllable cellular interactions for targeted drug delivery. His lab is focused on developing strategies for treating dysregulated immune responses such as allergy, inflammation, and cancer through the intersection of two enabling disciplines — nanotechnology and immune engineering. As a postdoctoral fellow at the University of Michigan, he championed projects related to nanoparticle engineering and protein delivery for antigenspecific tolerance induction (i.e., autoimmunity, allergens, allogeneic cell transplantation). Notably, he contributed to the invention of CNP-101, an immune tolerance-inducing nanoparticle for the treatment of celiac disease, which has been licensed

by Takeda Pharmaceutical Co. As a graduate student at the University of Illinois at Chicago, Pearson worked to synthesize and evaluate novel polymer molecular architectures based on dendrimers and linear-block copolymers. His research led to discoveries that improved the fundamental understanding of nanoparticle-biological interactions and strategies to overcome critical challenges associated with targeted drug delivery. Since 2009, Pearson has published 22 manuscripts in high-impact journals that have been cited more than 800 times. He is an inventor on three patents associated with biomaterials for immunomodulation, and is an active member of the board of directors for the Controlled Release Society ImmunoDelivery Focus Group.

Zafari is a quantitative outcomes researcher with interests in a wide range of applied and theoretical topics in health economics, outcomes research, and health policy, including developing advanced cohort/micro simulation models for cost-effectiveness or comparative effectiveness of health policies or technologies, Bayesian methods of synthesizing and reconciling evidence, statistical methods of longitudinal analyses, prospective, or retrospective studies including multi-level (hierarchical) modeling, age-period-cohort analysis, and non- or semi-parametric modeling to address burning epidemiological and health policy questions. He received a PhD in health economics and outcomes research in 2016 at the University of British Columbia. During his PhD, he worked as a mathematical modeler and data scientist affiliated with the Center for Clinical Epidemiology and Evaluation and as a health economist/epidemiologist for the Center of Collaborations for Outcomes Research and Evaluation. He received a MSc in mathematics from the University of British Columbia in 2012, and a BSc in electrical engineering from Tehran Polytechnic University in Iran in 2010. Zafari was a postdoctoral research scientist in the Department of Health Policy and Management at Columbia University in New York from 2016 to 2018. During this time, in addition to working on a variety of projects on the cost effectiveness of social and preventive policies, he conducted research to quantify and understand the trends of sociological well-being over time and their impact on survival inequalities in the United States.

36

c a p su l e

www.pharmacy.umaryland.edu

GRANT AND CONTRACT AWARDS |

July 1, 2017– June 30, 2018

DEPARTMENT OF PHARMACEUTICAL HEALTH SERVICES RESEARCH (PHSR) PROJECT INVESTIGATOR

RANK/TITLE

PROJECT TITLE

SPONSOR NAME

Associate Professor

Secondment Agreement

BMJ Publishing Group Ltd., Inc.

Peter Doshi Associate Professor

Restoring Invisible and Abandoned Trials Support Center

Laura and John Arnold Foundation $348,404

Susan dosReis Professor

Center for Patient-Focused Value Assessment

Pharmaceutical Research and Manufacturers of America

$223,155

Susan dosReis Professor

State of Maryland Foster Care Psychotropic Database Monitoring

Maryland Department of Human Services

$100,652

Maya Hanna Graduate Student

PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS

Agency for Healthcare Research and Quality

$7,675

Maya Hanna Graduate Student

Geographic Variations of Screening and Diagnosis of Alzheimer’s Disease and Related Dementias in the U.S.

Pharmaceutical Research and Manufacturers of America

$25,000

C. Daniel Mullins Professor and Chair

PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS

Agency for Healthcare Research and Quality

$842,516

C. Daniel Mullins Professor and Chair

Mapping and Resourcing Patient and Stakeholder Engagement Along 10-Step PCOR Continuum Framework

Patient-Centered Outcomes Research Institute

$399,321

C. Daniel Mullins Professor and Chair

Pragmatic Clinical Trials of Proton vs. Photon Therapy for Patients with Breast and Lung Cancer

University of Pennsylvania

$104,385

C. Daniel Mullins

Merck/UMB SOP HEOR Fellowship

Merck & Co. Inc.

$105,073

C. Daniel Mullins Professor and Chair

Patient-Centered Outcomes Research Scientific and Lay Training

Westat Inc.

$213,017

C. Daniel Mullins Professor and Chair

Increasing Patient-Community Capacity to Engage on Quality of Health Care Research and Programs

National Health Council

$12,500

C. Daniel Mullins Professor and Chair

Direct Medical Costs of Alpha-1 Antitrypsin Deficiency in the United States

Alpha-1 Foundation

$157,753

C. Daniel Mullins Professor and Chair

Improving FDA Health Communications University of Maryland, with Older Women Regarding FDA College Park Regulated Products

Peter Doshi

Professor and Chair

PROJECT TOTAL

$90,000

$162,000

sp ring 2 0 2 0

37

GRANT AND CONTRACT AWARDS

Elisabeth Oehrlein Graduate Student

PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS

Agency for Healthcare Research and Quality

$7,657

Ebere Onukwugha Associate Professor

PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS

Agency for Healthcare Research and Quality

$83,195

Ebere Onukwugha Associate Professor

Non-Hodgkins Lymphoma SEER Medicare Proposal: Health Economics and Outcomes Research

Bayer Pharma AG

$150,393

Eleanor Perfetto Professor

Outcome Measures of Hospitalization from Bleeding Events from Anticoagulant Medication Use

Pharmacy Quality Alliance

$16,488

Eleanor Perfetto Professor

An Intensive Introduction to the Science University of Maryland, of Clinical Outcomes Assessment (COA) College Park – A COA Online Continuing Education Series

$74,986

Eleanor Perfetto Professor Hypoglycemic Events Requiring a

Hospital Admission or ED Visit

Associated with Anti-Hyperglycemic Medications

Pharmacy Quality Alliance

$150,000

Fadia Shaya Professor

Maryland Department of Health

$380,000

Fadia Shaya Professor Substance Abuse Block Grant Amendment

Maryland Department of Health

$72,000

Fadia Shaya Professor

Social Marketing Campaign, Technical Assistance and Evaluation

Maryland Department of Health

$120,000

Fadia Shaya

Social Marketing Campaign Evaluation

Maryland Department of Health

$135,000

Fadia Shaya Professor

Implementation & Evaluation for the Strategic Prevention Framework for Prescription Drugs Initiative

Maryland Department of Health

$320,000

Fadia Shaya Professor

Technical Assistance and Evaluation of the Strategic Prevention Framework Partnership for Success Initiative

Maryland Department of Health

$215,000

Julia Slejko Assistant Professor

SEER-Medicare Study of Health Outcomes and Economics: Multiple Myeloma Supplement

Takeda Pharmaceutical Co. Ltd.

$300,000

38

c a p su l e

Professor

www.pharmacy.umaryland.edu

Evaluation and Technical Assistance Services for the Maryland Substance Abuse Prevention and Treatment Block Grant Prevention Program

GRANT AND CONTRACT AWARDS

Julia Slejko Assistant Professor

Literature Review of Claims-Based Measures for Oral Oncology Drugs

Novartis Pharmaceuticals Corp.

$154,003

Ester Villalonga-Olives Assistant Professor

PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS

Agency for Healthcare Research and Quality

$15,120

Linda Wastila Parke-Davis Chair

of Geriatric Pharmacotherapy

Linda Wastila Parke-Davis Chair

of Geriatric Pharmacotherapy

Statewide Epidemiological Outcomes Workgroup

Maryland Department of Health

$200,000

Shared Savings Calculations

Maryland Health Care Commission $60,385

Linda Wastila Parke-Davis Chair

of Geriatric Pharmacotherapy

Novartis HEOR Fellowship

Novartis Pharmaceuticals Corp.

$114,011

Linda Wastila Parke-Davis Chair

of Geriatric Pharmacotherapy

Novartis HEOR Fellowship

Novartis Pharmaceuticals Corp.

$109,420

Linda Wastila Parke-Davis Chair

of Geriatric Pharmacotherapy

Shared Savings Calculations

Maryland Health Care Commission $65,420

Linda Wastila Parke-Davis Chair

of Geriatric Pharmacotherapy

Novartis HEOR Fellowship

Novartis Pharmaceuticals Corp.

$109,420

PHSR Total

$5,643,949

DEPARTMENT OF PHARMACY PRACTICE AND SCIENCE (PPS) PROJECT INVESTIGATOR

RANK/TITLE

Bruce Anderson Professor

PROJECT TITLE

Denver Health and Hospital Authority WO# 34 and 35

SPONSOR NAME

PROJECT TOTAL

Denver Health and Hospital Authority

$27,799

Bruce Anderson Professor State Children’s Health Insurance Program

Maryland Department of Health

$2,824,120

Bruce Anderson Professor

Poison Center Support and Enhancement

Health Resources and Services Administration

$212,188

Bruce Anderson Professor

Enhanced Toxidromic Surveillance Using Poison Center Data

Maryland Department of Health

$70,000

sp ring 2 0 2 0

39

GRANT AND CONTRACT AWARDS

Bruce Anderson

Professor

Naloxone Surveillance Project

Maryland Department of Health

$199,976

Geriatrics Workforce Enhancement Program

Johns Hopkins University School of Medicine

$55,000

Nicole Brandt Professor MedStar Good Samaritan Hospital

Service Agreement

Nicole Brandt Professor Modernization, Testing & Validation of

Alternate Formats of the Medicare

Part D MTM Program Standardized Format

Good Samaritan Hospital

$29,934

Academy of Managed Care Pharmacy

$72,645

Nicole Brandt Professor

Kimberly Claeys Assistant Professor

Maryland Department of Health

$200,000

Nicole Brandt Professor

Antimicrobial Stewardship in the Post-Acute Long-Term Care Setting

Improving Clinical Outcomes in Gram- MAD-ID: Making a Difference in Negative Bacteremia Through a 24-Hour Infectious Diseases Multidisciplinary Verigene Gram-Negative Blood Culture Treatment Pathway

$27,222

Kimberly Claeys Assistant Professor Comparing the Clinical Utility of Rapid

Diagnostics for the Treatment of Bacteremia

Society of Infectious Diseases Pharmacists

$9,039

Catherine Cooke Research Part D Enhanced Medication Therapy

Associate Professor Management Technical Implementation Support

IMPAQ International, LLC

$31,104

Catherine Cooke

Maryland Department of Health

$100,000

Research Associate Professor

Fill Status Notification to Improve Hypertension Management

Catherine Cooke Research

Associate Professor

PCORI Training for Minority Practitioners Patient-Centered Outcomes and Their Patients: Targeting the Silent Research Institute Killers of Cardiovascular Disease

$187,393

Bethany DiPaula Professor

Springfield Hospital Center – Pharmacy Services

Maryland Department of Health

$1,438,166

Bethany DiPaula Professor

Opioid Prescription Review for Pain Management

Maryland Department of Health

$135,816

Bethany DiPaula

Pharmacy Education Project

Maryland Department of Health

$196,987

Memorandum of Understanding - Prince George’s Hospital Center and University of Maryland, Baltimore

Dimensions Health Corp.

$609,827

FY18-19 Service Addendum #2

Johns Hopkins Hospital

$44,784

Professor

Natalie Eddington Dean and Professor

Agnes Ann Feemster Associate Professor

40

c a p su l e

www.pharmacy.umaryland.edu

GRANT AND CONTRACT AWARDS

Agnes Ann Feemster Associate Professor Memorandum of Understanding

for Joint Clinical and Educational Collaboration

Johns Hopkins Hospital

$44,236

Joga Gobburu

PK Analysis Plan

Collegium Pharmaceutical

$8,000

Joga Gobburu Professor

Use Pharmacokinetic Data for Modeling and Simulation of Pediatric Drug Trial Design

Sunovion Pharmaceuticals, Inc.

$25,000

Joga Gobburu Professor

New Drug Application Strategy and Modeling and Simulation Support

Upsher-Smith Laboratories, Inc.

$25,000

Joga Gobburu Professor

USL-261 PBPK Modeling and Regulatory Strategy

Proximagen, LLC

$100,000

Mathangi Research Gopalakrishnan Assistant Professor

Pharmacodynamic and Pharmacokinetic Wockhardt Ltd. Properties of Wockhardt’s WCK 9444 with Actraphane 30 and Simultaneous Injections of Lantus & Actrapid in Healthy Subjects

$25,000

Mathangi Research Gopalakrishnan Assistant Professor

A Randomized, Single Center, Double Blind, Two Treatment, Two Period, Crossover Glucose Clamp Study to Test for Bioequivalence between Wockhardt’s Consegna and Mixtard in Healthy Subjects

Wockhardt Ltd.

$25,000

Emily Heil Associate Professor

Society of Infectious Diseases Pharmacotherapy Residency Award

Society of Infectious Diseases Pharmacists

$60,000

Emily Heil Associate Professor

Oral Vancomycin plus Intravenous Metronidazole for Severe Clostridium Difficile NAP1/BI/027 Infection

American Association of Colleges of Pharmacy

$4,564

Emily Heil Associate Professor Clinical Outcomes with Ceftolozane-

Tazobactam in Patients with Multi Drug Resistant Pseudomonas aeruginosa Infections

Lauren Hynicka Associate Professor Hepatitis C Virus Review Program

Temple University – HSC

$2,997

Maryland Department of Health

$474,579

Vijay Ivaturi Research

Assistant Professor

Vijay Ivaturi Research

Assistant Professor

Pharmacometric Support for a Neuro- Oncology Drug Development Program

Upsher-Smith Laboratories, Inc.

$100,000

A Comparison of Buprenorphine Vs. Morphine in the Treatment of the Neonatal Ab

Thomas Jefferson University

$23,969

Professor

sp ring 2 0 2 0

41

GRANT AND CONTRACT AWARDS

Vijay Ivaturi

Research Assistant Professor

University of Minnesota

$12,888

Cherokee Layson-Wolf

Associate Professor FY18 Resident Training Agreement and Associate Dean

Sharpsburg Pharmacy

$23,461

Cherokee Layson-Wolf Associate Professor FY18 Resident Training Agreement

and Associate Dean

Raymond Love Professor Potomac Center - Secure Evaluation

and Therapeutic Treatment

Whitesell Pharmacy

$23,461

Maryland Department of Health

$164,180

Raymond Love Professor

Eastern Shore Hospital Center – Improving Pharmacy Services

Maryland Department of Health

$419,040

Raymond Love Professor

Spring Grove Hospital Center – Improving Pharmacy Services

Maryland Department of Health

$1,900,810

Raymond Love Professor

Clifton T. Perkins Hospital Center – Improving Pharmacy Services

Maryland Department of Health

$773,134

Raymond Love Professor

Raymond Love Professor

Raymond Love Professor

Thomas B. Finan Center – Improving Pharmacy Services

Maryland Department of Health

$384,696

MHA – Centralized Administration of Pharmacy Services

Maryland Department of Health

$556,813

Peer to Peer Review for Mental Health Drug Programs - Pediatrics

Maryland Department of Health

$2,400,000

Raymond Love Professor

Antipsychotic Prescription Review Program

Maryland Department of Health

$1,613,755

Ashlee Mattingly Assistant Professor

Clinical Use of Bulk Drug Substances Nominated for Use in Compounding

by Outsourcing Facilities

University of Maryland, College Park

$148,114

Joey Mattingly Associate Professor

Engaging an Underserved Patient Community to Inform and Improve Comparative Effectiveness Research for Hepatitis C Treatments

Patient-Centered Outcomes Research Institute

$49,500

Joey Mattingly Associate Professor

A Single-Center Pilot to Measure Self-Reported Health Confidence from an Outpatient Pharmacy Discharge Service and 30-day Readmission Rates

Bristol-Myers Squibb

$74,900

42

c a p su l e

www.pharmacy.umaryland.edu

ESETT Pharmacokinetic- Pharmacodynamic Study

GRANT AND CONTRACT AWARDS

Joey Mattingly Associate Professor

Pharmapreneur: Defining the Role of Entrepreneurialism in Schools of Pharmacy

American Association of Colleges of Pharmacy

$10,000

Mary Lynn McPherson Professor

Union Memorial PGY2 Pain and Palliative Care Residency

Union Memorial Hospital

$63,900

Jill Morgan

Professor and Chair

Medstar Georgetown University

MedStar Health Inc.

$71,020

Jill Morgan

Professor and Chair

IPA Agreement

VA Maryland Health Care System $24,831

Jill Morgan

Professor and Chair

Clinical Pharmacy Services

Maryland Department of Health

$186,668

Jason Noel

Associate Professor

Developmental Disablities Administration Maryland Department of Health

$48,204

PATIENTS: PATient-centered Involvement in Evaluating effectiveNess of TreatmentS

Agency for Healthcare Research and Quality

$7,675

Charmaine Rochester Professor Contraceptive Regulation

Implementation: Stakeholder Facilitation

Maryland Department of Health

$10,000

Magaly Rodriguez Professor and FY18 Clinical Pharmacy Services de Bittner Associate Dean

University of Maryland Baltimore Washington Medical Center

$92,581

Magaly Rodriguez Professor and de Bittner Associate Dean

Memorandum of Understanding for Joint Clinical and Educational Collaboration

University of Maryland Baltimore Washington Medical Center

$70,231

Magaly Rodriguez de Bittner

Professor and Associate Dean

Joint Clinical and Educational Collaboration

UM Quality Care Network, LLC

$308,135

Leah Sera

Assistant Professor

MedStar Montgomery Medical Center

MedStar Health Inc.

$76,667

Mona Tsoukleris Professor School Epinephrine Administration:

Electronic Database Development Consultation

Maryland Department of Health

$4,000

Total PPS

$16,909,009

Kathleen Pincus Associate Professor

DEPARTMENT OF PHARMACEUTICAL SCIENCES (PSC) PROJECT INVESTIGATOR

RANK/TITLE

Joel Brandis Graduate Student

PROJECT TITLE

Development of Bioanalytical Mass Spectrometric Approaches to Measure Iron Release in Plasma of Patients Treated with IV Iron Preparations

SPONSOR NAME

PROJECT TOTAL

American Foundation for Pharmaceutical Education

$10,000

sp ring 2 0 2 0

43

GRANT AND CONTRACT AWARDS

Andrew Coop

Professor and Associate Dean

Preclinical Identification of Better Antimuscarinic Antidepressants

University of Texas Health Science Center at San Antonio

$91,445

Alecia Dent Graduate Student The Non-Redundant Role of the Has

and Phu Heme Acquisition Systems of Pseudomonas aeruginosa in Iron Homeostasis

National Institutes of Health

$29,173

Brandon Drennen Graduate Student Towards a New Therapeutic Modality

for the Treatment of Alzheimer’s:

Interception of Transient Helical States

of beta-Amyloid with Small-Molecule Proteomimetics

American Foundation for Pharmaceutical Education

$10,000

Steven Fletcher Associate Professor

Washington University

$81,790

Steven Fletcher Associate Professor Enhancers of Reverse Cholesterol Transport

Maryland Industrial Partnerships

$68,253

David Goodlett Professor

Functional Characterization of the Bax-Interacting Factor-1 Interactome in Neurons

University of Washington

$18,756

Stephen Hoag Professor

Effect of pH of Smokeless Tobacco Products on the Pharmacokinetics of Nicotine in Current Users

Battelle Memorial Institute

$38,024

Preclinical and Clinical Imaging and Treatment of Multiple Myeloma with cMyc-Max Nanoparticles

Stephen Hoag Professor Professional Service for Manufacturing Food & Drug Administration an in vitro Component of an Assessment

of a Proposed in vitro Bioequivalence

Approach for Evaluating Generic and New

Animal Formulations

$32,000

Stephen Hoag Professor Formulation Development for Rare

Disease Therapy

Stephen Hoag Professor Methods For Evaluation of Abuse

Deterrence Via Smoking And Vaping

Maryland Industrial Partnerships

$68,252

National Institute of Pharmaceutical Technology and Education

$205,000

Lisa Jones Associate Professor

Mechanism of Transcription Regulation by the Mediator

Indiana University

$9,987

Lisa Jones Associate Professor

CAREER: Development of an In Cell Footprinting Method for the Analysis of Protein Structure

National Science Foundation

$219,677

44

c a p su l e

www.pharmacy.umaryland.edu

GRANT AND CONTRACT AWARDS

Lisa Jones Associate Professor

A Novel Protein Footprinting Method Coupled with Mass Spectrometry for the Structural Analysis of Class II CFTR Mutants

Cystic Fibrosis Foundation

$54,000

Lisa Jones Associate Professor

Development of an in vivo Footprinting Method Coupled with Mass Spectrometry in C. elegans

National Institutes of Health

$309,000

Maureen Kane Associate Professor

Molecular Determinants of Retinoid Metabolism in Embryonic Tissues

University of Kansas Center for Research, Inc.

$52,924

Alexander MacKerell Jr. Grollman-Glick

Professor

Program for Therapeutic Targeting of Transcriptional Repression

Samuel Waxman Cancer Research Foundation

$15,000

Alexander MacKerell Jr. Grollman-Glick Carbohydrate Force Fields for

Professor Structure, Dynamics, and Molecular Recognition

National Institute of General Medical Sciences

$357,085

Alexander MacKerell Jr. Grollman-Glick

Professor

Polarizable Force Field for Proteins and Lipids

University of Chicago

$195,840

Alexander MacKerell Jr. Grollman-Glick

Professor

Design and Synthesis of Inhibitors of the BTB Domain of BCL6

Joan & Sanford I. Weill Medical College of Cornell University

$239,110

Alexander MacKerell Jr. Grollman-Glick LRRK2 Dimerization and Therapeutic

Professor Evaluation

Johns Hopkins University

$60,515

Alexander MacKerell Jr. Grollman-Glick

Professor

Pre-Computed Free Energy Maps for Rapid Structure-Based Ligand Design

SilcsBio LLC

$153,610

Alexander MacKerell Jr. Grollman-Glick

Professor

Oligonucleotide Conformational Heterogeneity

National Institute of General Medical Sciences

$292,653

Alexander MacKerell Jr. Grollman-Glick

Professor

Molecular Characterization and Drug Design Targeting Emerging Pathogenic Bacteria of Pakistan and Development of an Access Application for the Health Care Industry

The National Academies

$51,599

Alexander MacKerell Jr. Grollman-Glick

Professor

Biased Agonism and Conformational Heterogeneity of Beta Adrenergic Receptors in Bronchodilation

Thomas Jefferson University

$77,250

National Science Foundation

$150,000

U.S. Army Research Office

$80,000

Sarah Michel

Professor and Non-Classical Zinc Finger Proteins Associate Dean

Sarah Michel Professor and

Associate Dean

Bioanalytical Mass Spectroscopic Approaches to Characterize ProteinStabilized Gold Nanoclusters

sp ring 2 0 2 0

45

GRANT AND CONTRACT AWARDS

Amanda Oglesby- Associate Professor Sherrouse

Role of PrrF and PrrH Regulation in Pseudomonas aeruginosa Pathogenesis

National Institute of Allergy and Infectious Diseases

$428,875

Amanda Oglesby- Associate Professor Sherrouse

Metallobiochemistry of Innate Immunity and Bacterial Physiology

Massachusetts Institute of Technology

$114,532

Amanda Oglesby- Associate Professor Sherrouse

Iron Regulation of CF Lung Pathogen Interactions

Cystic Fibrosis Foundation

$108,000

James Polli Shangraw/Noxell

Endowed Chair

University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)

University of Maryland, College Park

$410,086

James Polli Shangraw/Noxell

Endowed Chair

Evaluation of Metal Ions in Electronic Cigarette Aerosol Condensates and Determination of Their Effects on Oral Keratinocytes

University of Maryland, College Park

$188,610

James Polli Shangraw/Noxell

Endowed Chair

Development and Validation of a Clinically Relevant in vitro Dissolution Test for the Poorly Soluble, Weakly Basic Drug Itraconazole in Spray-Dried Amorphous Solid Dispersion

National Institute of Pharmaceutical Technology

$750,000

C.S. Raman Associate Professor

Jana Shen Professor

Redox Biochemistry of Energy Conservation in Methanogens and Their Syntrophic Partners

U.S. Department of Energy

$196,302

Thin Film Biofabrication for Integrated Bio-Electronics

University of Maryland, College Park

$80,000

Jana Shen Professor

Molecular Mechanisms of Secondary Active Transporters

Arizona State University

$73,681

Jana Shen Professor

Electrostatic Modulation of Protein Dynamics and Interactions

National Institute of General Medical Sciences

$347,625

Audra Stinchcomb Professor Bioequivalence of Topical Drug Products: in vitro - in vivo Correlations

Food & Drug Administration

$499,999

Audra Stinchcomb Professor

Heat Effect on Generic Transdermal Drug Delivery Systems

Food & Drug Administration

$499,999

Peter Swaan

Structural Biology of the Apical Bile Acid Transporter

National Institute of Diabetes & Digestive & Kidney Diseases

$350,326

Function and Regulation of SLC13A5 in the Liver

National Institute of General Medical Sciences

$297,413

Professor and Associate Dean

Hongbing Wang Professor

46

c a p su l e

www.pharmacy.umaryland.edu

GRANT AND CONTRACT AWARDS

Hongbing Wang Professor

Developing DL5016 as a Sensitizer for Cyclophosphamide-Based Treatment for Non-Hodgkins Lymphoma

Maryland Technology Development Corp.

$115,000

Angela Wilks Isaac E. Emerson Mechanistic Characterization and

Professor Regulation of the Non-Redundant phu

and has Heme Uptake Systems of

Pseudomonas aeruginosa

National Institute of Allergy and Infectious Diseases

$396,890

Patrick Wintrode Associate Professor Mechanisms of Glycosaminoglycan-

Catalyzed Protease Inactivation by Serpins

Vanderbilt University Medical Center

$55,085

Bruce Yu Professor Contact-Free Real-Time In-Line PAT

or Continuous Biomanufacturing

National Institute for $197,960 Innovation in Manufacturing Biopharmaceuticals

PSC Total

$8,081,326

Department of Pharmaceutical Health Services Research (PHSR)

$5,643,949

Department of Pharmacy Practice and Science (PPS)

$16,909,009

Department of Pharmaceutical Sciences (PSC)

$8,081,326

Grand Total

$30,634,284

sp ring 2 0 2 0

47

HONOR ROLL OF DONORS |

July 1, 2017 – June 30, 2018

Loyal donors provide the foundation for the School of Pharmacy’s success.

Thank you to everyone — our alumni, faculty, staff, and friends — who has invested in the University of Maryland School of Pharmacy.

LEGACY COUNCIL The Legacy Council of the University of Maryland acknowledges those who have made generous contributions to the School of Pharmacy through their estate plans.

Anyone who has made such a gift is eligible for membership in the Legacy Council. To qualify, simply provide the School of Pharmacy’s Office of Development and Alumni Affairs with documentation of the gift or a copy of the relevant document in which the School is named as a beneficiary (www.umbfplannedgiving.org). For additional information about membership in the Legacy Council and estate planning, please contact the Office of Development and Alumni Affairs at 410-706-5893 or email ggriffith@rx.umaryland.edu.

Members of the Legacy Council are: John H. Balch, BSP ’68 Roslyn F. Balch Thomas S. Brenner, BSP ’72 Barry M. Bress, BSP ’79 Theresa A. Bress Gary G. Buterbaugh, PhD Phyllis Brill Wingrat, BSP ’50= Billie Chappelear Harold E. Chappelear, DSc ’98 Gerald I. Cohen, BSP ’58=

Irwin R. Cohen= Kristine W. Ellinger, BSP ’77= Estate of Evelyn Grollman Glick Nancy Rose Harmon= Ilene Harris, BSP ’81, PharmD ’83 Gwynne L. Horwits Leonard Horwits, BSP ’60 George H. Huber, BSP ’61 Sophia Kallelis= Theodore S. Kallelis, PhD ’57=

Dolores H. Kinnard William J. Kinnard Jr., PhD Bernhard Lamy Gregory J. Lukaszczyk, BSP ’84 Estate of Bertha J. Manchey Estate of Helen Mendelsohn David G. Miller, BSP ’85 Joseph H. Morton, BSP ’60= Paul A. Pumpian, BSP ’50= Michael B. Rodell, BSP ’58

Chris A. Rodowskas, PhG ’29= Matthew Shimoda, PharmD ’84 Estate of Lillian K. Slama Allen Spak, BSP ’63= James M. Trattner, PhD ’28= Clayton L. Warrington, BSP ’58 Elizabeth Warrington William J. Zimmerman, BSP ’70 = Signifies Deceased

DAVID STEWART ASSOCIATES In the mid-1980s, several dedicated alumni and friends established a premier giving society, the David Stewart Associates (DSA), to fund Schoolwide initiatives that would propel the University of Maryland School of Pharmacy nationally as a leader in pharmacy education. This leadership giving society honors David Stewart, America’s first professor of pharmacy and a founder of the University of Maryland School of Pharmacy, who symbolized a passion for excellence and commitment to pharmacy education.

The founding members of the DSA are: Elwin Alpern, BSP ’51=

Mayer Handelman, BSP ’54

Martin B. Mintz, PD, BSP ’65

Arthur N. Riley, BSP ’70, MS ’72

Leon R. Catlett, BSP ’65

William M. Heller, MS ’51,

Benjamin S. Mulitz

Gerald M. Rosen

Melvin S. Cohen=

PhD ’55, DSC ’87

Elizabeth Newcomb, BSP ’68

David M. Russo, BSP ’79

James P. Cragg Jr., BSP ’43=

H. Elinor Hens=

John R. Newcomb Jr., BSP ’67

Ralph A. Small Jr., BSP ’74

Leonard J. DeMino=

Leon Jablon=

Anthony G. Padussis, BSP ’44=

Arnold Smolen

Donald O. Fedder, BSP ’50=

William J. Kinnard Jr.

David Pearlman, BSP ’52

Bernard A. Weisman, BSP ’70=

Michaeline R. Fedder

Dorothy Levi, BSP ’70

William L. Pearlman, BSP ’48=

Kenneth P. Whittemore Jr.,

Robert Foer, BSP ’51=

Mark A. Levi, PD, BSP ’70

Thomas S. Petr, BSP ’74

BSP ’76

Henry J. Glaser Jr.=

Samuel Lichter, BSP ’60

Stephen J. Provenza, PhG ’29=

Leonard Winkleman

Evelyn Grollman Glick=

Nicholas C. Lykos, BSP ’52=

Lawrence R. Rachuba=

= Signifies Deceased

This core group of philanthropists has inspired other donors to follow their lead. Today DSA membership has grown to create a solid base of private support for the School’s efforts to advance pharmaceutical education, practice, and science. To join this prestigious group of alumni and friends, or for more information on giving to the School, please contact the Office of Development and Alumni Affairs at 410-706-5893 or email ggriffith@rx.umaryland.edu.

48

c a p su l e

www.pharmacy.umaryland.edu

HONOR ROLL OF DONORS

The University of Maryland School of Pharmacy appreciates the financial support of the following individuals and organizations during the period July 1, 2017, to June 30, 2018.

GIVING BY INDIVIDUALS

Julian M. Friedman, BSP '56*

Gerolyn Ann Whittemore~

Mark H. Masich

Mary Therese Gyi, BSP '83,

Kenneth P. Whittemore Jr.,

Lisa M. Matson, BSP '88*

David Stewart Associates

Jason M. Noel~

Over $500,000

Ilene Harris, BSP '81, PharmD ’83~

Alice A. Williams, PharmD '12~

Eberechukwu Onukwugha~

Ellen H. Yankellow, BSP ’73,

William M. Heller, MS ’51

Carol Ann Williams~

Glenda S. Owens, BSP ’76~

Robert W. Henderson, BSP ’63*

Thomas G. Williams Jr.,

Kimberly M. Palasik, BSP '88

Walter J. Hryszko, BSP '74*

Raymond A. Palasik, BSP '88

PharmD ’96*

PharmD '06*

BSP '76*

PharmD '06~

$100,000 - $499,999

Maureen Kane

Hannah Jones

Jonathan Kang

Dean’s Club

Doris M. Peng, MS '78

David H. Jones, BSP ‘70~

David A. Knapp*

$500 - $999

Shelby D. Reed, BSP '93, PhD '99

Jill R. Molofsky, BSP ‘81*

Deanne E. Knapp*

Lauren Barbour, PharmD ’16

Bruce D. Roffé, MS '78~

James P. Tristani, BSP ’73*

Calvin H. Knowlton, PhD '93~

Marie Boyden

Pritesh K. Shah, PharmD '01

Raymond C. Love, PharmD '77*

Michelle M. Ceng, PharmD '98*

Julia F. Slejko~

$10,000 - $24,999

Michael Luzuriaga, BSP '70*

Rebecca Ceraul~

Frances Spaven, PhD '86*

Beverly L. Crovo~

Daniel Z. Mansour, PharmD '06~

Lisa Calvert Chalk

Kerry Spaven~

Thomas L. Crovo~

Alexander D. MacKerell Jr.~

Youjin Chang, PharmD '13

Craig K. Svensson, PharmD '81*

Martin B. Mintz, BSP '65*+

David D. Christ, BSP '79*

Susan Svensson

$5,000 - $9,999

Jill A. Morgan~

David P. Cline, PhD '03

George W. Swope Jr., BSP '70

Thomas S. Brenner, BSP ‘72*

C. Daniel Mullins*

Nicholas Cornias, BSP '92*

Jia-Bei Wang, PhD '92~

Jogarao Gobburu

Thomas S. Petr, BSP '74*

Surabhi Y. Dangi-Garimella,

Junling Wang, MS '04, PhD '05

Andrew V. Phan, PharmD ’13

Angela Wilks~

$1,000 - $4,999

Casey Phan

Mary David

Gary J. Wirth, BSP '79

Barbara Alving~

Keith S. Pozanek, BSP '86*

Joseph A. Demino, BSP '84

Loreen A. Wutoh, BSP '86*

Carl Alving~

Arthur N. Riley, BSP '70, MS '72

Leslie D. Frank, BSP '77, PhD '82

Richard L. Wynn, BSP '64,

Andrew Bartilucci, PhD '53*

Jane M. Shaab

Tushar S. Garimella, PhD '05

Christopher M. Blanchette,

Marilyn Shangraw*

Mark D. Gately

Candice Yong, PhD '15

Paul Shapiro~

Andrew Glorioso, BSP '72

Kenneth Boyden~

Elias Shaya

Yara K. Haddad, PharmD '10

Apothecary Club

Cynthia J. Boyle, PharmD '96~

Fadia T. Shaya

Barry D. Hecht, BSP '73

$250 - $499

James L. Bresette, PharmD '97*

Jeffrey B. Sherr, BSP '78*

Alice H. Hill, PharmD ’93*

Stephen J. Allen, MS '78~

Yale H. Caplan, BSP ’63, PhD ’68*

Joanne H. Sherr, BSP '78*

R. Gary Hollenbeck

Wendy Allen~

Suzanne J. Caplan, BSP ’65

Lisa A. Shipley, PhD ’86

Brian M. Hose, PharmD '06~

Marsha E. Alvarez, BSP '71,

Andrew Coop*

Gisele M. Sidbury, PharmD '97~

Stacey Hose~

William J. Cooper*

Larry E. Small, MS '76, PhD ’80*

Karen M. Kabat, MS '83*

Bruce Anderson~

Conrad Peter Dorn Jr., BSP '58

Edward A. Taylor, PharmD '06~

Hee S. Kim, BSP '90

Laurine A. Barrow-Wilson,

Susan C. dosReis, PhD ’99~

Jackie Tran, PharmD ’13

Wendy Klein-Schwartz,

Natalie D. Eddington, PhD ’89*

Melike G. Tunc, PharmD '08

Sherry N. Berlin, BSP '74*

Ira L. Fedder, PharmD '79~

Pinar Tunc

Lisa T. Kloch, BSP '80

Howard K. Besner, BSP '78*

Michaeline R. Fedder

Zeynep T. Tunc, PharmD '06

Stephen C. Kloch, BSP '80*

Charles R. Bonapace, PharmD '97*

J. Philip Fink, BSP '79*

Angelo C. Voxakis, BSP '71*

Kan Chan Ku, PharmD '01

Luke Brewer

Mark G. Fletcher, BSP ’78, MS ’81,

Clayton L. Warrington, BSP ’58*

Suneel Kudaravalli, PharmD '00~

Harold Chappelear, LLD (Hon) ’98~

Elizabeth Warrington~

Neil B. Leikach, BSP '92*

Barbara S. Chong, PharmD '97~

PhD '07

PhD ’83

* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years

Neha Pandit

PhD '05

PharmD '77*

+ Signifies David Stewart Associates Founding Member = Signifies Deceased

PhD '70*

PharmD ’96*

BSP '89~

sp ring 2 0 2 0

49

HONOR ROLL OF DONORS

Tatiana Claro da Silva, PhD '11

Loc K. Dang, BSP '82~

Gayle C. Howell, BSP '91~

Terrence Clemmons, MS '15

Century Club

Daniel A. Diggins Jr., BSP '85

Helen Hsiao, PharmD '06~

James M. Crable, BSP '82~

$100 - $249

Bethany A. DiPaula, PharmD '95

Ronald W. Huffman

Pamela M. Crowe~

Stephanie L. Agelopas, BSP '83

Peter Doshi

Lauren M. Hynicka

Ramesh Dandu, PhD '08

Omoniyi A. Agunbiade,

Dongyi Du, PhD '09~

Vijay Ivaturi

Terry L. Davis, BSP '83,

Ping Jin Du

Cindy Q. Jiang, BSP '90~

Jung Akiyama, PharmD '00

Michelle L. Eby, PharmD '99~

Hao Jiang~

Colleen Day~

Fernando Andrickson, PharmD '08

Donald B. Elliott, BSP '57*

Sophia L. Johnson

Omolola O. Elliott, BSP '92

Yndiana Tineo Andrickson,

Lily Chua Eng, BSP '76

Tali M. Johnson, PharmD '02~

William T. Foley Jr., BSP '58*

Susan M. Evans, BSP '91~

Angel N. Jordan, PharmD '06

Gregory P. Honshul, BSP '75

Clarence L. Anstine, BSP '58~

Daniel A. Farney, PharmD '01~

Patrick Y. Kamara, PharmD '98~

Charise S. Kasser, BSP '83*

Daniel Ashby

Margaret R. Ferguson

Erika L. Kammer, PharmD '08

Jonathan N. Latham, PharmD '98*

Theophilus E. Awuah, PharmD '00

Herbert Friedman, BSP '50~

Susan A. Katz, BSP '88*

Lisa Lebovitz~

Dov E. Banks~

Joyce Friedman

Thomas H. Keller Jr., BSP '63*

Ashlee Mattingly

Freddy E. Banks, BSP '92~

Stephen S. Friedman, BSP '82

Lauretta A. Kerr, BSP ’86

Joey Mattingly, PhD '18

Marshal Banks~

Denise Fu, PharmD '10

Yelee Y. Kim, PharmD '01~

Maura P. Murphy, PhD '99~

Rochelle Banks~

Stephen J. Gandel, BSP '62~

Nelson E. Kline, BSP '92

Sai C. Nimmagadda, PharmD '12~

Robin L. Becker, BSP '84~

Florence F. K. Gee, BSP '74*

William Knebel, PharmD '97

Barbara B. Nussbaum, BSP '89~

Vahram Bedrossian, BSP '79

Maria A. Giannas, PharmD '00

Michael J. Kopcho, MS '62

Kristine Rapan Parbuoni,

Phyllis A. Bernard, BSP '88*

Donald J. Glenn, BSP '83*

Lawrence J. Kotey, PharmD '03~

Thomas J. Biles, PharmD '98~

Brian J. Goetz, PharmD '94*

Julie A. Kreyenbuhl, PhD '99

Eleanor M. Perfetto

Barry L. Bloom, BSP '66*

Mathangi Gopalakrishnan

Edmond J. Kucharski, BSP '84*

Thomas J. Pfaff, BSP '85*

Renan A. Bonnel, PharmD '83

Sarah Grebow

Kathrin C. Kucharski, PharmD '87*

Bonnie L. Pitt, BSP '74~

Stephen P. Boykin, BSP '73,

Greer Griffith

Thomas P. LaMartina, BSP '87*

Jingjing Qian, PhD '12

Deborah F. Groleau~

Kaysha R. Lancaster, PharmD '00~

Pamela N. Roberto, MS '15

John E. Braaten, BSP '79*

George E. Groleau, BSP '76~

Kirk K. Lancaster~

Michael B. Rodell, BSP '58*

Nicole J. Brandt, PharmD '97~

Alicia M. Gronseth, PharmD '11

Ronald E. Lay, BSP '78*

Thomas H. Root, PharmD '00

Robert P. Brauner, BSP '65~

Anthony A. Guerra, PharmD '97

Lisa C. LeGette, BSP '92*

James R. Salmons, BSP '89

Becky A. Briesacher, PhD '01

Joseph G. Handelman, BSP '60

Colleen C. Lehmann, BSP '78~

Sorell L. Schwartz, BSP '59

Elaine L. Brogan, BSP '78*

Sandy Harriman

Henry M. Levi, BSP '63*

Suzanne K. Simala, BSP '84*

Huong T. Bui Dang, BSP '82~

Diana P. Henzel, BSP '93*

Bonnie Levin, BSP '78

Kara J. Sink, BSP '92*

Wendy Camelo-Castillo

Laura J. Herb

Norman L. Levin, BSP '57

Tye D. Souders, PharmD '13

Linda W. Canady, PharmD '06

Mary-Therese Hewins, BSP '81,

Julie E. Limric, BSP '69*

Marc Taraban

Marian L. Cascio, BSP '77*

Dale E. Lintner Jr.

Andrea B. Weiss, BSP ’89*

Jason F. Chancey, PharmD '00*

Frederick M. Hindman, PharmD '17

Denise Lupo Lutz, BSP '77*

Fred M. Weiss, BSP '70*

Juliana Lee Chau, BSP '79

Miriam Kamanitz Hirsch, BSP '76

Frederick J. Mack, BSP '79*

Robert Wixson

Viktor Chirikov, MS ’15, PhD ’15

Stephen W. Hoag~

Walter P. Mackay, BSP '62*

Bay-Mao B. Wu, PharmD '01*

Catherine L. Cioffi, PhD '88~

G. Lawrence Hogue, BSP '69

Daniel F. Mackley, BSP '76*

William Yeboah, PharmD '00*

Arnold E. Clayman, BSP '73*

Kellie Hom

Harry E. Macks, BSP '59~

David M. Yoder, PharmD '98*

Wendy Cohan~

Gwynne L. Horwits*

Jeanne Macks

Susan Cohen-Pessah, BSP '78

Leonard Horwits, BSP '60*

Lawrence L. Martin, BSP '66*

Kimberly Anne Compton, BSP '94

Tamara Howard, BSP '88,

Carolyn S. Mason, BSP '84

David A. Custer, BSP '73*

Edward T. McCagh Jr., BSP '75*

Hedy J. Cylus Gleiman, BSP '73*

Forest S. Howell, BSP '87*

PharmD '98*

PharmD '05~

50

c a p su l e

PharmD '06

PharmD '08

MS ’76~

www.pharmacy.umaryland.edu

MS '84*

PharmD '01

* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years

Kevin F. McCarthy, BSP '80*

+ Signifies David Stewart Associates Founding Member = Signifies Deceased

HONOR ROLL OF DONORS

Gina Patrice McKnight-Smith,

Michael J. Steinberg, PharmD '00*

Abimbola O. Adebowale,

Nicole Caprio, PharmD '16

Jae Hyung Carpenter, PharmD '98

Alan R. Stoff, BSP '70*

Rachel L. Melnick, PharmD '11~

PharmD '97*

Kathryn M. Strong, PharmD '97

Asmita Adhikari

Deborah G. Carroll, BSP '72

Steven J. Miller, MS '87*

Donald W. Taylor, BSP '69~

Mary Afrane, PharmD '15

Jennifer L. Carroll, BSP '92

Yvonne K. Molotsi, PharmD '02*

Nancy L. Taylor, BSP '62*

Lawrence Aiken, BSP '73*

Malissa Carroll

Kathleen M. Morneau, PharmD '11

Sheryl E. Thedford, PharmD '11~

Clement O. Akogyeram,

Joy Y. Chai, PharmD '12

John M. Motsko Jr., BSP '69

Terri A. Thompson Cathers,

William C. Charles, PharmD '11

Arinzechukwu P. Nwanokwai,

Husam A. Albarmawi, MS '16

Andrew Chayasriwong,

Francis J. Tinney, PhD '66*

Kirk N. Alexander, BSP '75

Dora M. Ober, PharmD '90~

Mary J. Tooey

Nichole D. Althouse, PharmD '13

Hansong Chen, PharmD '13

Joseph D. Ober, PharmD ’85*

Denise P. Toyer-McKan,

Burton A. Amernick

Marvin J. Chertkoff, BSP '51,

Joseph Pariser, BSP '63

Alan W. Anthony, PharmD '04

Sharon K. Park, PharmD '04~

Thanh T. Tran, BSP '90~

Caroline T. Bader, BSP '81*

Jennifer A. Cho, PharmD '14

Angela M. Parker, BSP '95*

Tracy R. Travers, BSP '95

Janice Baer

Deborah S. Chou

Lynn M. Perry

Mona L. Tsoukleris, PharmD '87

Marc Baer

Kenneth E. Cohen

Philip M. Perry, BSP '74*

Shannon R. Tucker

Ingrid R. Baramki, MS '63*

Michael J. Cohen, BSP '66*

Anthony J. Petralia Sr., BSP '52*

Anthony O. Uwadia, PharmD '11

Donna M. Barrett, BSP '77

Dana S. Corn, BSP '70*

Carolyn Petralia, PharmD '03*

Joseph E. Vandigo, MS '15, PhD '18

William H. Batt, BSP '63*

Ryan Costantino, MS '19

Judith A. Porter

Donna E. VanWie, BSP '87

Michael G. Beatrice, PhD '01

Brittany C. Couto, PharmD '16

Rana Rais, PhD '10

Wayne D. VanWie, BSP '88*

John A. Beckman, BSP '76

Randy L. Crispin, BSP '79

Lois A. Reynolds, PharmD '01~

George C. Voxakis, BSP '58,

Katherine P. Benderev, BSP '77,

Eric E. Daniels, MS '17

James R. Ritchie, BSP '63*

David G. Danziger, BSP '51

Howard L. Robinson Jr.,

Hongbing Wang~

Alvin M. Blitz, BSP '67

Robert J. Davis Sr., PharmD '78

PharmD '15

PharmD '00~

PharmD '97

PharmD '98

PharmD ’96*

PhD '99~

PharmD '97

PharmD ’79~

PharmD '19

MS ’54~

Yanhong Wang

Susan C. Bloom

Pamela E. Deiss, BSP '85

Magaly Rodriguez de Bittner,

Linda Wastila~

Thomas V. Bolling, BSP '69*

Mary Eckert DeLuca, BSP '79*

Fran Weiskopf, PharmD '88*

Curtis A. Bowen, BSP '56*

Alecia Dent

Joseph M. Ruppel, BSP '75*

PharmD '83*

Andrew Wherley, PharmD '19

Laura M. Bozzi, MS '14

Christopher W. Dobroth,

Lisa Coppolo Ruppel, PharmD '90

Emily S. Wiener, PharmD '15

Lynette R. Bradley-Baker, BSP '92,

Laura E. Sampson, BSP '87

Fengtian Xue

John P. Dolan, PharmD '14

Brian L. Schumer, BSP '81*

Hawyee T. Yan, BSP '83

Toni Brafa-Fooksman

Charles R. Downs, BSP '73,

Mark W. Sellers, PharmD '03

Irvin Yospa, BSP '61*

Joel Brandis

Steven B. Shannon, PharmD '11

Donald R. Young, BSP '57*

Patrick K. Brannen, PharmD '99

Patricia E. Draper, BSP '83

Stuart Shapiro

Y. Bruce Yu

Jeffrey M. Brewer, PharmD '98

Nancy A. Dravis, BSP '81

Christopher L. Shawyer, BSP '76*

William V. Zappa, BSP '74*

Margaret C. Brophy, BSP '77

Norman DuBois, BSP '53*

Yan Shu

Gene G. Zepp, BSP '48~

Roberta L. Brown, PharmD '80

Erin S. Dudley, PharmD '09

John C. Smith, BSP '76*

Reid A. Zimmer, BSP '63*

Marian C. Bruce

Kathleen E. Dury

Stephen L. Buckner, BSP '67

Sharon I. Early, PharmD '97

Judith Wenzel Smith, BSP '77*

PhD '99*

PharmD '15

PharmD ’99*

Larry A. Snyder, BSP '60*

Contributions up to $99

Jennifer T. Bui, PharmD '89

Jasmine M. Ebron, PharmD '16

Rona S. Snyder*

Cordelia N. Abazie, PharmD '05

Leslie J. Burgess, PharmD '03

Hillary A. Edwards

Adams O. Solola, PharmD '04

Jennifer A. Abernathy, PharmD '13

Michael A. Burns, BSP '88

Odera I. Ekwunife, PharmD ’19

Kaitlyn M. Solola, PharmD '04

Lawrence M. Abrams, BSP '55*

Melanie Byrd

Rodney Elliott

Nina H. Spiller, PharmD '88*

Dennis M. Ackerman, BSP '70*

Martin J. Calabrese

Michael J. Evanko Jr., BSP '73

Molrat Sripinyo, BSP '83*

Marie V. Adams~

Dianna L. Campbell, PharmD '16

Karla D. Evans, BSP '93

Charles H. Steg Jr., BSP '78

Robert W. Adams, BSP '68*

Stanley Caplan, BSP '70

Cheryl Fahlman, PhD '03

* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years

+ Signifies David Stewart Associates Founding Member = Signifies Deceased

sp ring 2 0 2 0

51

HONOR ROLL OF DONORS

Jill R. Fetter, BSP '93*

Lori A. Hollis, PharmD '92

Elizabeth Klutts

Janet L. Mighty, BSP '82~

Robert D. Fetter

Paul Holly

Charles J. Kokoski, BSP '51,

Margaret Miklich

Jerome L. Fine, BSP '56,

Kyungwan Hong

Harris L. Miller, BSP '65*

PharmD ’96

MS ‘53, PhD '56*

Yoon Duk Hong, PharmD '17

Diana J. Kozuch

Jennifer Miller

Lisa Finn

Ronald M. Hopkins, BSP '63

Patricia Kpolie

Matthew Mills

Robyn E. Firmin, PharmD '17

Arley Hunter, PharmD '09

Lawrence J. Krebs, PharmD '06

Kellie M. Monzillo, PharmD '06

Melissa G. Fiscus, PharmD '17

Nigel Roger Isaacs, PharmD '93~

Aida E. Kuzucan, PharmD '15

Steven Monzillo

Devon M. Flynn, PharmD '05

Anthony M. Ishak, PharmD '02

Olayinka Ladeji

Karen Morales

Jack H. Freedman, BSP '70

Jeanine E. Jackson, PharmD '05

Angela Lamy

Thomas L. Morgan, BSP '93*

Erin P. Freeman, PharmD '14

Paul F. Jarosinski, BSP '76

Mark H. Lapouraille, BSP '84

Jeffrey S. Mrowczynski,

Paul Freiman, BSP '53~

Clarence A. Jeffers III, BSP '75

Ivy I. Laryea-Akogyeram,

Phyllis Freiman~

Abree Johnson

Elizabeth S. Murias, BSP '84

Jack Frieman, BSP '56

Lisa M. Johnson-Pope,

Stephen L. Lauer, BSP '62

Hyung J. Na, BSP '89

Adele Fu

Cherokee L. Layson-Wolf,

Paul J. Na, BSP '90

Priyanka Gaitonde, MS '16,

Jace Jones

Nabil Natafgi

PhD '18

PharmD '99

BSP '93~

PharmD '00~

PharmD '13~

Lisa Jones

Calvin Y. Lee, PharmD '04

Barbrakaryne N. Nchinda Fobi,

Aakash Bipin Gandhi

Louis M. Jones, PharmD '09

Richard Lee

Ankit Gandhi, PharmD '19

Michael E. Jones, BSP '72*

Yoon-Hee C. Lee, PharmD '02

Katherine E. Nelson, PharmD '12

Thelma R. Ganser

John T. Jordan Jr., PharmD '95

Joseph H. Lerner, BSP '60

Heather Neu

Patricia H. Gaskin, BSP '58

Susan E. Jordan, BSP '94

Melvin Lessing, BSP '66*

Kwabena O. Nimarko,

Stephen M. Gerardi, BSP '75

Teny Joseph, PharmD '19

Dorothy Levi, BSP '70

Doris Titus Glover

Carl Kaiser, MS '52, BSP ’53,

Siyun Liao, PharmD '11

Heather A. Nizer, PharmD '96

Jeffrey Gonzales

Susana Mourino Lopez

Andongfac Nkobena, PharmD '16

Bruce M. Gordon, BSP '79,

Angela M. Kaitis, BSP '75,

Daniel C. Lyons, PharmD '07~

Chidubem N. Nwankwo,

Gary H. Magnus, BSP '81

PharmD '82

PhD '55* PharmD ’06~

PharmD '15

PharmD '17

PharmD '01

Emily F. Gorman

Beatrice A. Kallungal, MS '15

Ann G. Mantelmacher, BSP '80

Naitia M. Nwatu, PharmD '15

Lee H. Gradman, BSP '57

Rachna Kapoor, PharmD '05

Clifford W. Mason, PhD '08

Elisabeth Oehrlein, PhD '18

Frances A. Gray, PharmD '13

Robert Karrs

Nachi A. Mbinkar, PharmD '13

Amanda Oglesby-Sherrouse

Martin D. Grebow, BSP '60*

Trinh Michelle Keelin,

David J. McCaffrey III, BSP '90

Ihuoma U. Onyewuchi,

Laura Gressler

Madeline McCarren, PhD '83~

Julie Lynne Groff

Dianna N. Kenner-Staves,

Matthew E. McGovern, BSP '91~

Eleanor A. O'Rangers,

Shauna D. Guest

Earl A. McLaren, BSP '89

Stephanie Hale, PharmD '08

Tsedeke Ketema

Alexandra L. McPherson,

Mary E. Ortiz, BSP '87*

Whitney N. Hanson, PharmD ’10

Eric Kettering

Robin L. Paluskievicz,

Jeffrey J. Harnsberger, BSP '92~

Lena Kim, PharmD '18

Mary Lynn McPherson,

Ann Harris

Stonewall C. King Jr., MS '60

Si Yeon Park

Lois T. Havranek, BSP '60~

Hellen N. Kiruthi, PharmD '02

Lori Ann Mears, BSP '82

Ha K. Phan, PharmD '17

Mojdeh Heavner, PharmD '08

Kathryn Kiser

Erin Merino

Dominique N. Phelps, BSP '86

Carl L. Heifetz, BSP '57

Eliford N. Kitabi

Stanley J. Merwitz, BSP '54*

Deborah J. Pippin, PharmD '06

Sandra Heifetz

Ronald P. Kleiman, BSP '82

Jonathan A. Meyer, PharmD '17

Cristina V. Platon, BSP '83*

Emily Heil

Barbara Klein

Wayne M. Meyers

Marvin S. Platt, BSP '51*

Geoffrey A. Heinzl, PhD '16

Linda C. Klein, BSP '72*

Sara K. Meyers-Clark, BSP '91

James Polli

Bernard P. Heyman, BSP '57~

Kathleen Klemm, PharmD '08~

Sarah L. Michel

Stuart L. Porter

52

c a p su l e

PharmD '02 PharmD '16

www.pharmacy.umaryland.edu

PharmD '15 PharmD '86*

* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years

PharmD ’16 PharmD ’90

PharmD '98*

+ Signifies David Stewart Associates Founding Member = Signifies Deceased

HONOR ROLL OF DONORS

Apoorva Pradhan

Arvin P. Shroff, PhD '62

Yunga Vercelline, BSP '93

Carl Kaiser, BSP

Bryan P. Prazak, PharmD '06

Stephanie E. Shulder, PharmD '15

Ester Villalonga Olives

Charles J. Kokoski, MS

Julie Preis, PharmD '99

Jan Sieluk, PhD '18

Lisa A. Vuolo

Jordan Pritts

Harriet Silverstein~

Reenie T. Wagner

Class of 1954

Danya Qato

Morton I. Silverstein, BSP '54*

Andrew J. Walker

Marvin J. Chertkoff, MS

Kimberly Raines-Isler, PhD '06

Cheryl Simmons-Gray,

Mary Walter

Stanley J. Merwitz, BSP

Sangeeta V. Raje, PhD '02~

James C. Wang, PharmD '11~

Morton I. Silverstein, BSP

Kumaran Ramakrishnan,

Matthew O. Siuta, PharmD ’11

Mingxiang Wang, PharmD '13

Meagan C. Small, PhD '15

Allie Wasik

Class of 1955

Budne C. Reinke, BSP '63*

Olufunke Sokan

Brenda K. Weller, BSP '92*

Lawrence M. Abrams, BSP

Luann Orehek Reno, BSP '89~

Jerry A. Solomon

Charles T. Wells III, PharmD '01

Carl Kaiser, PhD

Blair M. Robinson

O'Mareen Spence

Monica L. White, PharmD '95~

David J. Seff, BSP

Elizabeth Robinson

Kathleen J. Sremcich,

Liyi Wu

Milton F. Toelle, BSP

Gertrude M. Robinson

Sharyn Yenzer

Kathryn A. Robinson

Johanna L.M. Stengel

Christian A. Zang~

Class of 1956

Mary Joe Robl, BSP '52

Todd H. Stephens, BSP '93~

Chengchen Zhang

Curtis A. Bowen, BSP

Charmaine Rochester

Patricia Stewart

Julie Magno Zito~

Jerome L. Fine, BSP

John Roskos Jr., MS '56

Abigail M. Strawberry, BSP '93*

Barry Rothberg

James P. Struntz Sr., BSP '61~

Robert F. Royce, BSP '51*

Kim Sullivan

Juan-David Rueda, MS '16,

Thomas J. Sullivan

Class of 1948

Charles Summerlin, PharmD '19

Gene G. Zepp, BSP

PharmD '17

PhD '19

PharmD '99

PharmD '01

Julian M. Friedman, BSP DONORS BY CLASS YEAR

Jack Frieman, BSP Charles J. Kokoski, PhD John Roskos Jr., MS Class of 1957

Soumi Saha, PharmD '07

Peter Swaan

Tracy M. Salaam, PharmD '02

Pat Swain

Class of 1950

Donald B. Elliott, BSP

Kristina San Juan

John H. Sybert, BSP '94

Herbert Friedman, BSP

Lee H. Gradman, BSP

I. N. Sanders

Seyed E. Tabibi, PhD '82~

Andrew R. Sandler

Liza N. Takiya, PharmD '97~

Class of 1951

Bernard P. Heyman, BSP

Elizabeth Sanford

Charles D. Taylor Jr., BSP '67,

Marvin J. Chertkoff, BSP

Norman L. Levin, BSP

Amanda Schartel

David G. Danziger, BSP

Donald R. Young, BSP

Chad Scheuerell

Himali Thakkar, PharmD '13

William M. Heller, MS

Christie H. Scheuerell, MS '16

Danny R. Timney, PharmD '02

Charles J. Kokoski, BSP

Class of 1958

Teresa A. Schweiger, BSP '94

Milton F. Toelle, BSP '55*

Marvin S. Platt, BSP

Clarence L. Anstine, BSP

Morton J. Sclar, BSP '60

Patricia Torano

Robert F. Royce, BSP

Conrad Peter Dorn Jr., BSP

David J. Seff, BSP '55*

Deanna Tran, PharmD '11~

Leah C. Sera, PharmD '10~

Charles H. Tregoe, BSP '59*

Class of 1952

Patricia H. Gaskin, BSP

Savyasachi Shah

Matthew Tyrie

Carl Kaiser, MS

Michael B. Rodell, BSP

Kelly L. Shaner-Miller, BSP '92

Paige Tyrie

Anthony J. Petralia Sr., BSP

George C. Voxakis, BSP

Thomas S. Shelor, BSP '74*

Lori J. Ukleja, BSP '89

Mary Joe Robl, BSP

Clayton L. Warrington, BSP

Adrienne M. Shepardson,

Meltem Unal

PharmD ’00*

Carl L. Heifetz, BSP

William T. Foley Jr., BSP

Kimberly S. Updegraff, BSP '91

Class of 1953

Class of 1959

Matthew G. Shimoda,

Greg Vasas

Andrew Bartilucci, PhD

Harry E. Macks, BSP

Neal K. Vasist, PharmD '12

Norman DuBois, BSP

Sorell L. Schwartz, BSP

Tina L. Vassalotti, BSP '89

Paul Freiman, BSP

Charles H. Tregoe, BSP

PharmD '05 PharmD '84*

Soo Hyeon Shin, PhD '18

* Signifies donor for 15+ consecutive years ~ Signifies donor for 5-14 consecutive years

+ Signifies David Stewart Associates Founding Member = Signifies Deceased

sp ring 2 0 2 0

53

HONOR ROLL OF DONORS

Class of 1960

Class of 1966

Andrew Glorioso, BSP

Glenda S. Owens, BSP

Martin D. Grebow, BSP

Barry L. Bloom, BSP

Michael E. Jones, BSP

Christopher L. Shawyer, BSP

Joseph G. Handelman, BSP

Michael J. Cohen, BSP

Linda C. Klein, BSP

Larry E. Small, MS

Lois T. Havranek, BSP

Melvin Lessing, BSP

Arthur N. Riley, MS

John C. Smith, BSP

Leonard Horwits, BSP

Lawrence L. Martin, BSP

Stonewall C. King, MS

Francis J. Tinney, PhD

Joseph H. Lerner, BSP

Kenneth P. Whittemore Jr., BSP Class of 1973 Lawrence Aiken, BSP

Class of 1977

Morton J. Sclar, BSP

Class of 1967

Stephen P. Boykin, BSP

Donna M. Barrett, BSP

Larry A. Snyder, BSP

Alvin M. Blitz, BSP

Arnold E. Clayman, BSP

Katherine P. Benderev, BSP

Stephen L. Buckner, BSP

David A. Custer, BSP

Margaret C. Brophy, BSP

Charles D. Taylor Jr., BSP

Hedy J. Cylus Gleiman, BSP

Marian L. Cascio, BSP

Class of 1961 James P. Struntz Sr., BSP Irvin Yospa, BSP Class of 1962

Charles R. Downs, BSP

Leslie D. Frank, BSP

Class of 1968

Michael J. Evanko Jr., BSP

Wendy Klein-Schwartz, PharmD

Robert W. Adams, BSP

Barry D. Hecht, BSP

Raymond C. Love, PharmD

Yale H. Caplan, PhD

James P. Tristani, BSP

Denise Lupo Lutz, BSP

Ellen H. Yankellow, BSP

Judith Wenzel Smith, BSP

Stephen J. Gandel, BSP Michael J. Kopcho, MS

Class of 1969

Stephen L. Lauer, BSP

Thomas V. Bolling, BSP

Class of 1974

Class of 1978

Walter P. Mackay, BSP

G. Lawrence Hogue, BSP

Sherry N. Berlin, BSP

Stephen J. Allen, MS

Arvin P. Shroff, PhD

Julie E. Limric, BSP

Florence F. K. Gee, BSP

Howard K. Besner, BSP

Nancy L. Taylor, BSP

John M. Motsko Jr., BSP

Walter J. Hryszko, BSP

Elaine L. Brogan, BSP

Donald W. Taylor, BSP

Philip M. Perry, BSP

Susan Cohen-Pessah, BSP

Thomas S. Petr, BSP

Robert J. Davis Sr., PharmD

Class of 1963 Ingrid R. Baramki, MS

Class of 1970

Bonnie L. Pitt, BSP

Mark G. Fletcher, BSP

William H. Batt, BSP

Dennis M. Ackerman, BSP

Thomas S. Shelor, BSP

Ronald E. Lay, BSP

Yale H. Caplan, BSP

Stanley Caplan, BSP

William V. Zappa, BSP

Colleen C. Lehmann, BSP

Robert W. Henderson, BSP

Dana S. Corn, BSP

Ronald M. Hopkins, BSP

Jack H. Freedman, BSP

Class of 1975

Doris M. Peng, MS

Thomas H. Keller Jr., BSP

David H. Jones, BSP

Kirk N. Alexander, BSP

Bruce D. Roffe, MS

Henry M. Levi, BSP

Dorothy Levi, BSP

Stephen M. Gerardi, BSP

Jeffrey B. Sherr, BSP

Joseph Pariser, BSP

Michael Luzuriaga, BSP

Gregory P. Honshul, BSP

Joanne H. Sherr, BSP

Budne C. Reinke, BSP

Arthur N. Riley, BSP

Clarence A. Jeffers III, BSP

Charles H. Steg Jr., BSP

James R. Ritchie, BSP

Alan R. Stoff, BSP

Angela M. Kaitis, BSP

Reid A. Zimmer, BSP

George W. Swope Jr., BSP

Edward T. McCagh Jr., BSP

Class of 1979

Fred M. Weiss, BSP

Joseph M. Ruppel, BSP

Vahram Bedrossian, BSP

Class of 1964

Bonnie Levin, BSP

Richard L. Wynn, PhD

Richard L. Wynn, BSP

Katherine P. Benderev, PharmD Class of 1976

John E. Braaten, BSP

Class of 1971

John A. Beckman, BSP

Barry M. Bress, BSP

Class of 1965

Marsha E. Alvarez, BSP

Stephen P. Boykin, MS

Juliana Lee Chau, BSP

Robert P. Brauner, BSP

Angelo C. Voxakis, BSP

Lily Chua Eng, BSP

David D. Christ, BSP

George E. Groleau, BSP

Randy L. Crispin, BSP

Suzanne J. Caplan, BSP Harris L. Miller, BSP

Class of 1972

Miriam Kamanitz Hirsch, BSP

Mary Eckert DeLuca, BSP

Martin B. Mintz, BSP

Thomas S. Brenner, BSP

Paul F. Jarosinski, BSP

Ira L. Fedder, PharmD

Deborah G. Carroll, BSP

Daniel F. Mackley, BSP

J. Philip Fink, BSP

54

c a p su l e

www.pharmacy.umaryland.edu

HONOR ROLL OF DONORS

Bruce M. Gordon, BSP

Charise S. Kasser, BSP

Class of 1988

Class of 1992

Frederick J. Mack, BSP

Madeline McCarren, PhD

Phyllis A. Bernard, BSP

Freddy E. Banks, BSP

Gary J. Wirth, BSP

Cristina V. Platon, BSP

Michael A. Burns, BSP

Lynette R. Bradley-Baker, BSP

Magaly Rodriguez de Bittner,

Catherine L. Cioffi, PhD

Jennifer L. Carroll, BSP

Class of 1980

PharmD

Tamara Howard, BSP

Nicholas Cornias, BSP

Roberta L. Brown, PharmD

Molrat Sripinyo, BSP

Susan A. Katz, BSP

Omolola O. Elliott, BSP

Lisa T. Kloch, BSP

Hawyee T. Yan, BSP

Lisa M. Matson, BSP

Jeffrey J. Harnsberger, BSP

Stephen C. Kloch, BSP

Kimberly M. Palasik, BSP

Lori A. Hollis, PharmD

Ann G. Mantelmacher, BSP

Class of 1984

Raymond A. Palasik, BSP

Nelson E. Kline, BSP

Kevin F. McCarthy, BSP

Robin L. Becker, BSP

Nina H. Spiller, PharmD

Lisa C. LeGette, BSP

Larry E. Small, PhD

Joseph A. Demino, BSP

Wayne D. VanWie, BSP

Neil B. Leikach, BSP

Mary-Therese Hewins, MS

Fran Weiskopf, PharmD

Kelly L. Shaner-Miller, BSP

Class of 1981

Edmond J. Kucharski, BSP

Caroline T. Bader, BSP

Mark H. Lapouraille, BSP

Class of 1989

Jia-Bei Wang, PhD

Nancy A. Dravis, BSP

Carolyn S. Mason, BSP

Laurine A. Barrow-Wilson, BSP

Brenda K. Weller, BSP

Mark G. Fletcher, MS

Elizabeth S. Murias, BSP

Jennifer T. Bui, PharmD

Ilene Harris, BSP

Matthew G. Shimoda, PharmD

Natalie D. Eddington, PhD

Class of 1993

Mary-Therese Hewins, BSP

Suzanne K. Simala, BSP

Earl A. McLaren, BSP

Karla D. Evans, BSP

Hyung J. Na, BSP

Jill R. Fetter, BSP

Gary H. Magnus, BSP

Kara J. Sink, BSP

Jill R. Molofsky, BSP

Class of 1985

Barbara B. Nussbaum, BSP

Diana P. Henzel, BSP

Brian L. Schumer, BSP

Pamela E. Deiss, BSP

Luann Orehek Reno, BSP

Alice H. Hill, PharmD

Craig K. Svensson, PharmD

Daniel A. Diggins Jr., BSP

James R. Salmons, BSP

Nigel Roger Isaacs, PharmD

Joseph D. Ober, PharmD

Lori J. Ukleja, BSP

Calvin H. Knowlton, PhD

Thomas J. Pfaff, BSP

Tina L. Vassalotti, BSP

Ivy I. Laryea-Akogyeram, BSP

Andrea B. Weiss, BSP

Thomas L. Morgan, BSP

Class of 1982 Huong T. Bui Dang, BSP James M. Crable, BSP

Class of 1986

Loc K. Dang, BSP

Lauretta A. Kerr, BSP

Class of 1990

Todd H. Stephens, BSP

Leslie D. Frank, PhD

Mary Lynn McPherson, PharmD

Cindy Q. Jiang, BSP

Abigail M. Strawberry, BSP

Stephen S. Friedman, BSP

Dominique N. Phelps, BSP

Hee S. Kim, BSP

Yunga Vercelline, BSP

Bruce M. Gordon, PharmD

Keith S. Pozanek, BSP

David J. McCaffrey III, BSP

Ronald P. Kleiman, BSP

Lisa A. Shipley, PhD

Paul J. Na, BSP

Class of 1994

Lori Ann Mears, BSP

Frances Spaven, PhD

Dora M. Ober, PharmD

Kimberly Anne Compton, BSP

Janet L. Mighty, BSP

Loreen A. Wutoh, BSP

Eleanor A. O'Rangers, PharmD

Brian J. Goetz, PharmD

Lisa Coppolo Ruppel, PharmD

Susan E. Jordan, BSP

Thanh T. Tran, BSP

Teresa A. Schweiger, BSP

Seyed E. Tabibi, PhD Class of 1987

Shelby D. Reed, BSP

Class of 1983

Forest S. Howell, BSP

Stephanie L. Agelopas, BSP

Kathrin C. Kucharski, PharmD

Class of 1991

Renan A. Bonnel, PharmD

Thomas P. LaMartina, BSP

Susan M. Evans, BSP

Class of 1995

Terry L. Davis, BSP

Steven J. Miller, MS

Gayle C. Howell, BSP

Bethany A. DiPaula, PharmD

Patricia E. Draper, BSP

Mary E. Ortiz, BSP

Matthew E. McGovern, BSP

John T. Jordan Jr., PharmD

Mark G. Fletcher, PhD

Laura E. Sampson, BSP

Sara K. Meyers-Clark, BSP

Angela M. Parker, BSP

Donald J. Glenn, BSP

Mona L. Tsoukleris, PharmD

Kimberly S. Updegraff, BSP

Tracy R. Travers, BSP

Mary Therese Gyi, BSP

Donna E. VanWie, BSP

John H. Sybert, BSP

Monica L. White, PharmD

Ilene Harris, PharmD Karen M. Kabat, MS

sp ring 2 0 2 0

55

HONOR ROLL OF DONORS

Class of 1996

Michelle L. Eby, PharmD

Sangeeta V. Raje, PhD

Bryan P. Prazak, PharmD

Marshall E. Alvarez, PharmD

Lisa M. Johnson-Pope, PharmD

Tracy M. Salaam, PharmD

Kimberly Raines-Isler, PhD

Cynthia J. Boyle, PharmD

Julie A. Kreyenbuhl, PhD

Danny R. Timney, PharmD

Edward A. Taylor, PharmD

Jerome L. Fine, PharmD

Maura P. Murphy, PhD

Heather A. Nizer, PharmD

Julie Preis, PharmD

Class of 2003

George C. Voxakis, PharmD

Shelby D. Reed, PhD

Leslie J. Burgess, PharmD

Ellen H. Yankellow, PharmD

Cheryl Simmons-Gray, PharmD

David P. Cline, PhD

Class of 2007

Cheryl Fahlman, PhD

Christopher M. Blanchette, PhD

Class of 1997

Class of 2000

Lawrence J. Kotey, PharmD

Daniel C. Lyons, PharmD

Clement O. Akogyeram, PharmD

Jung Akiyama, PharmD

Carolyn Petralia, PharmD

Soumi Saha, PharmD

Charles R. Bonapace, PharmD

Theophilus E. Awuah, PharmD

Mark W. Sellers, PharmD

Nicole J. Brandt, PharmD

Jason F. Chancey, PharmD

James L. Bresette, PharmD

Maria A. Giannas, PharmD

Class of 2004

Fernando Andrickson, PharmD

Barbara S. Chong, PharmD

Suneel Kudaravalli, PharmD

Alan W. Anthony, PharmD

Yndiana Tineo Andrickson,

Sharon I. Early, PharmD

Kaysha R. Lancaster, PharmD

Calvin Y. Lee, PharmD

PharmD

Anthony A. Guerra, PharmD

Cherokee L. Layson-Wolf,

Sharon K. Park, PharmD

Ramesh Dandu, PhD

William Knebel, PharmD

PharmD

Adams O. Solola, PharmD

Stephanie Hale, PharmD

Gina Patrice McKnight-Smith,

Howard L. Robinson Jr., PharmD

Kaitlyn M. Solola, PharmD

Mojdeh Heavner, PharmD

PharmD

Thomas H. Root, PharmD

Junling Wang, MS

Erika L. Kammer, PharmD

Gisele M. Sidbury, PharmD

Michael J. Steinberg, PharmD

Kathryn M. Strong, PharmD

Charles D. Taylor Jr., PharmD

Class of 2005

Clifford W. Mason, PhD

Liza N. Takiya, PharmD

William Yeboah, PharmD

Cordelia N. Abazie, PharmD

Melike G. Tunc, PharmD

Terri A. Thompson Cathers,

Zeynep T. Tunc, PharmD Thomas G. Williams Jr., PharmD

Class of 2008

Kathleen Klemm, PharmD

Surabhi Y. Dangi-Garimella, PhD Class of 2001

Devon M. Flynn, PharmD

Class of 2009

Michael G. Beatrice, PhD

Tushar S. Garimella, PhD

Dongyi Du, PhD

Class of 1998

Becky A. Briesacher, PhD

Jeanine E. Jackson, PharmD

Erin S. Dudley, PharmD

Thomas J. Biles, PharmD

Daniel A. Farney, PharmD

Rachna Kapoor, PharmD

Arley Hunter, PharmD

Jeffrey M. Brewer, PharmD

Tamara Howard, PharmD

Kristine Rapan Parbuoni, PharmD

Louis M. Jones, PharmD

Jae Hyung Carpenter, PharmD

Yelee Y. Kim, PharmD

Adrienne M. Shepardson,

Michelle M. Ceng, PharmD

Kan Chan Ku, PharmD

PharmD

Class of 2010

Harold Chappelear, LLD (Hon)

Chidubem N. Nwankwo, PharmD

Junling Wang, PhD

Denise Fu, PharmD

Terry L. Davis, PharmD

Lois A. Reynolds, PharmD

Patrick Y. Kamara, PharmD

Pritesh K. Shah, PharmD

Class of 2006

Whitney N. Hanson, PharmD

Jonathan N. Latham, PharmD

Kathleen J. Sremcich, PharmD

Omoniyi A. Agunbiade, PharmD

Rana Rais, PhD

Robin L. Paluskievicz, PharmD

Charles T. Wells III, PharmD

Linda W. Canady, PharmD

Leah C. Sera, PharmD

Denise P. Toyer-McKan, PharmD

Bay-Mao B. Wu, PharmD

Mary Therese Gyi, PharmD

PharmD

David M. Yoder, PharmD

Yara K. Haddad, PharmD

Brian M. Hose, PharmD

Class of 2011

Class of 2002

Helen Hsiao, PharmD

William C. Charles, PharmD

Class of 1999

Anthony M. Ishak, PharmD

Angel N. Jordan, PharmD

Tatiana Claro da Silva, PhD

Abimbola O. Adebowale, PhD

Tali M. Johnson, PharmD

Angela M. Kaitis, PharmD

Alicia M. Gronseth, PharmD

Lynette Bradley-Baker, PhD

Trinh Michelle Keelin, PharmD

Lawrence J. Krebs, PharmD

Siyun Liao, PharmD

Patrick K. Brannen, PharmD

Hellen N. Kiruthi, PharmD

Daniel Z. Mansour, PharmD

Rachel L. Melnick, PharmD

Susan C. dosReis, PhD

Yoon-Hee C. Lee, PharmD

Kellie M. Monzillo, PharmD

Kathleen M. Morneau, PharmD

Charles R. Downs, PharmD

Yvonne K. Molotsi, PharmD

Deborah J. Pippin, PharmD

Steven B. Shannon, PharmD

56

c a p su l e

www.pharmacy.umaryland.edu

HONOR ROLL OF DONORS

Matthew O. Siuta, PharmD

Arinzechukwu P. Nwanokwai,

Jan Sieluk, PhD

Affiliates

Sheryl E. Thedford, PharmD

PharmD

Joseph E. Vandigo, PhD

$10,000-$24,999

Deanna Tran, PharmD

Naitia M. Nwatu, PharmD

Anthony O. Uwadia, PharmD

Pamela N. Roberto, MS

Class of 2019

James C. Wang, PharmD

Stephanie E. Shulder, PharmD

Andrew Chayasriwong, PharmD

American Foundation for

American Association of Colleges of Pharmacy

Meagan C. Small, PhD

Ryan Costantino, MS

Class of 2012

Joseph E. Vandigo, MS

Odera I. Ekwunife, PharmD

Samuel Waxman Cancer

Joy Y. Chai, PharmD

Emily S. Wiener, PharmD

Ankit Gandhi, PharmD

Katherine E. Nelson, PharmD

Candice Yong, PhD

Teny Joseph, PharmD

Teledyne Hanson Research

Sai C. Nimmagadda, PharmD

Pharmaceutical Education Research Foundation

Juan-David Rueda, PhD

Jingjing Qian, PhD

Class of 2016

Charles Summerlin, PharmD

Sponsors

Neal K. Vasist, PharmD

Husam A. Albarmawi, MS

Andrew Wherley, PharmD

$1,000-$9,999

Alice A. Williams, PharmD

Lauren Barbour, PharmD

Abbott Laboratories

Dianna L. Campbell, PharmD

Albertsons

Class of 2013

Nicole Caprio, PharmD

GIVING BY CORPORATIONS

ASHP Foundation

Jennifer A. Abernathy, PharmD

Brittany C. Couto, PharmD

AND FOUNDATIONS

Baltimore Community

Nichole D. Althouse, PharmD

Jasmine M. Ebron, PharmD

Youjin Chang, PharmD

Priyanka Gaitonde, MS

Patrons

CVS Health Foundation

Hansong Chen, PharmD

Geoffrey A. Heinzl, PhD

$100,000 +

Equashield, LLC

Frances A. Gray, PharmD

Dianna N. Kenner-Staves,

Alpha-1 Foundation

Exxon Mobil Foundation

Nachi A. Mbinkar, PharmD

PharmD

Cystic Fibrosis Foundation

Fidelity Charitable Gift Fund

Jeffrey S. Mrowczynski, PharmD

Andongfac Nkobena, PharmD

Laura and John Arnold

FLAVORx

Andrew V. Phan, PharmD

Ihuoma U. Onyewuchi, PharmD

Foundation

Hereford Pharmacy, Inc.

Tye D. Souders, PharmD

Juan-David Rueda, MS

Merck & Co. Inc.

Huseyin Tunc Memorial Fund, Inc.

Himali Thakkar, PharmD

Christie H. Scheuerell, MS

International Society for Benefactors

Pharmacoeconomics &

Class of 2017

$50,000-$99,999

Outcomes Research

Jackie Tran, PharmD Mingxiang Wang, PharmD

Foundation

Eric E. Daniels, MS

Academy of Managed Care

Northern Pharmacy & Medical

Class of 2014

Robyn E. Firmin, PharmD

Pharmacy

Equipment

Laura M. Bozzi, MS

Melissa G. Fiscus, PharmD

MedStar Health

SilcsBio, LLC

Jennifer A. Cho, PharmD

Frederick M. Hindman, PharmD

Pharmaceutical Research and

UMSOP Class of 2017

John P. Dolan, PharmD

Yoon Duk Hong, PharmD

Walgreens

Erin P. Freeman, PharmD

Jonathan A. Meyer, PharmD

Society of Infectious Diseases

Manufacturers of America

Waters Corp.

Kwabena O. Nimarko, PharmD

Pharmacists

Class of 2015

Ha K. Phan, PharmD

Springer Science + Business

Contributors up to $999

Mary Afrane, PharmD

Kumaran Ramakrishnan, PharmD

Media LLC-NJ

AB&J RX Corp.

Viktor Chirikov, MS, PhD

Alpha Zeta Omega Kappa

Terrence Clemmons, MS

Class of 2018

Associates

Chapter

Christopher W. Dobroth, PharmD

Priyanka Gaitonde, PhD

$25,000-$49,999

Brookneal Drug Co.

Beatrice A. Kallungal, MS

Lena Kim, PharmD

Making a Difference in Infectious

Cape St. Claire Volunteer Fire Co.

Aida E. Kuzucan, PharmD

Joey Mattingly, PhD

Diseases

Catonsville Pharmacy

Alexandra L. McPherson, PharmD

Elisabeth Oehrlein, PhD

Fibus Drug Store

Barbrakaryne N. Nchinda Fobi,

Soo Hyeon Shin, PhD

Finksburg Pharmacy

PharmD

sp ring 2 0 2 0

57

HONOR ROLL OF DONORS

Gilchrist Hospice Care

GIFTS OF TRIBUTE

Good Shepherd Preschool

This is a listing of gifts received from July 1, 2017, to June 30, 2018. We have made every effort to provide

Jarrettsville Pharmacy

The School of Pharmacy

a complete and accurate listing of donors and

Levin & Gann, P.A.

received gifts of tribute for the

gifts. If we have made an error or omission, please

Network for Good

individuals listed below:

accept our sincere apology and contact the Office of

Seasons Hospice and

In Honor Of:

Development and Alumni Affairs at 410-706-5893 or

Harold Chappelear, LLD (Hon)

ggriffith@rx.umaryland.edu so that we may correct

C. Daniel Mullins, PhD

our records.

Palliative Care

SNC Partners LLC The Pfizer Foundation, Inc. Wedgwood Club

In Memory Of: Yvette A. Beakes, PharmD Dennis E. Ferguson, BSP Aaron Grebow, BSP Dean Ellis Leavitt, BSP, MS Brylene S. Schwartz Huseyin C. Tunc, BSP Herbert C. Wagner, BSP Bernard A. Weisman, BSP Thomas G. Williams Sr., PharmD Martin W. Wolff Jr., PhD.

58

c a p su l e

www.pharmacy.umaryland.edu

When you make a gift to the School’s Annual Fund…

Your gift counts as a vote of confidence, demonstrating your support for the University of Maryland School of Pharmacy.

Unrestricted gifts provide a crucial bridge between tuition revenue and the actual cost of operations, offering budgetary relief and directly affecting students, faculty, and numerous programs across the School. Most importantly, unrestricted gifts — regardless of the size — allow the dean to respond to the School’s most pressing financial concerns and provide flexibility to seize unique and important opportunities that advance practice, science, research, pharmapreneurship, and community service.

Unrestricted gifts to the University of Maryland School of Pharmacy’s Annual Fund help: › Strengthen financial aid programs, which defray the cost of tuition and expenses › Ensure that facilities are kept in excellent condition › Fund important faculty research initiatives › Support the operating budget › Provide flexibility to meet the School’s changing needs › Allow for the retention and expansion of our world-class faculty

Please consider making your Annual Fund gift today by visiting www.pharmacy.umaryland.edu/go/give or by making a check out to the University of Maryland Baltimore Foundation, Inc. and placing it in the envelope provided within this issue of Capsule.

A Gift That Keeps on Giving More than half of School of Pharmacy students rely on scholarships, fellowships, and financial aid to make their dream of becoming a pharmacist or researcher a reality.

As a student in the School’s Pharmapreneurship Pathway within the PharmD program, president of the University’s Entrepreneurship and Innovation Network, and a finalist in the School’s annual “America’s Got Regulatory Science Talent” competition, Jordan Fraker embodies all of the qualities of a strong pharmapreneur. As such, she was named the inaugural recipient of the Felix A. KhinMaung-Gyi Memorial Scholarship for Pharmapreneurship, the largest scholarship in the School’s history, which provides one full year of tuition.

In the journey to develop a new idea or product, we as entrepreneurs become accustomed to failure and quickly learn that we must be our own source of encouragement,” she says. “Receiving recognition from others through awards and scholarships such as the Felix A. KhinMaung-Gyi Memorial Scholarship goes beyond encouragement. It reinforces my work and gives me a sense of comfort that I am on the right path and that others believe in my endeavors. I am incredibly grateful to the Gyi family for their support. ­­­— Jordan Fraker Third-Year Student Pharmacist

Please contact Ken Boyden, JD, EdD, associate dean for development and alumni affairs, at kboyden@ rx.umaryland.edu or 410-706-3816 to create an endowed scholarship to benefit the next generation of pharmacists and researchers.

60

c a p su l e

www.pharmacy.umaryland.edu

MESSAGE FROM DEVELOPMENT

Ken Boyden

Be thoughtful. Be smart. Bequest.

Include a gift to the University of Maryland School of Pharmacy in your will.

At the University of Maryland School of Pharmacy, we are working hard to push the boundaries of education, research, practice, and service, putting ideas into action and harnessing the School’s potential to improve lives in our classrooms, our labs, our clinics, our communities, and around the world.

For years, bequests have benefited all aspects of the School, supporting everything from scholarships and fellowships, to research, to programs that spark innovation and shape the future of health care. No matter your passion, when you include the School in your will, you enhance the areas that you care about in a meaningful way. Charitable bequests can be a great way to give back because they are easy to establish, cost you nothing today, and are 100 percent free of federal estate taxes.

Choosing to remember the University of Maryland School of Pharmacy with a gift in your will is a wise and thoughtful way to fuel the School’s power of expertise, influence, and impact.

Contact us for bequest language specific to your giving situation. Your estate gift also will entitle you to membership in the School’s Legacy Council — our way of thanking you for your impactful generosity.

Thank you for your ongoing support.

Ken Boyden, JD, EdD Associate Dean Office of Development and Alumni Affairs 410-706-4415 kboyden@rx.umaryland.edu

Nonprofit Organization U.S. Postage

PAID Permit No. 4695

20 N. Pine Street Baltimore, MD 21201-1180

Baltimore, Maryland

Connect on RxIntersect!

We invite you to check out RxIntersect, our online networking platform that ensures every University of Maryland School of Pharmacy student and alumnus has the professional connections needed to succeed. We know that finding a job can be daunting, so making the most of your connections is important. To give you a leg up, we recently have added a job board where alumni can see and post jobs.

Through RxIntersect, you can virtually connect and network with more than 6,000 alumni, students, and faculty from the School of Pharmacy. It’s a convenient and efficient way to:

} Share experiences

} Exchange career advice

} Build professional networks based on interests and career tracks

} Search for jobs within your field

Visit rxintersect.umaryland.edu to participate.

Click “Join the Community” to register with either your LinkedIn account or an email address.